<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Med J Islam Repub Iran</journal-id>
<journal-id journal-id-type="iso-abbrev">Med J Islam Repub Iran</journal-id>
<journal-id journal-id-type="publisher-id">Med J Islam Repub Iran</journal-id>
<journal-id journal-id-type="publisher-id">MJIRI</journal-id>
<journal-id journal-id-type="publisher-id">Med J Islam Repub Iran</journal-id>
<journal-title-group>
<journal-title>Medical Journal of the Islamic Republic of Iran</journal-title>
</journal-title-group>
<issn pub-type="ppub">1016-1430</issn>
<issn pub-type="epub">2251-6840</issn>
<publisher>
<publisher-name>Iran University of Medical Sciences</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">32617267</article-id>
<article-id pub-id-type="pmc">7320976</article-id>
<article-id pub-id-type="doi">10.34171/mjiri.34.28</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Molecular biomarkers in diabetes mellitus (DM)</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Aghaei Zarch</surname>
<given-names>Seyed Mohsen</given-names>
</name>
<xref ref-type="aff" rid="A01">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Dehghan Tezerjani</surname>
<given-names>Masoud</given-names>
</name>
<xref ref-type="aff" rid="A02">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Talebi</surname>
<given-names>Mehrdad</given-names>
</name>
<xref ref-type="aff" rid="A01">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">https://orcid.org/0000-0003-0535-1590</contrib-id>
<name>
<surname>Vahidi Mehrjardi</surname>
<given-names>Mohammad Yahya</given-names>
</name>
<xref ref-type="corresp" rid="COR1">*</xref>
<xref ref-type="aff" rid="A03">
<sup>3</sup>
</xref>
</contrib>
</contrib-group>
<aff id="A01">
<sup>1</sup>Department of Medical Genetics, Shahid Sadoughi University of Medical Sciences, Yazd, Iran</aff>
<aff id="A02">
<sup>2</sup>Yazd Reproductive Sciences Institute, Shahid Sadoughi University of Medical Sciences, Yazd, Iran</aff>
<aff id="A03">
<sup>3</sup>Diabetes Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran</aff>
<author-notes>
<corresp id="COR1"><italic><bold>Corresponding author:</bold></italic> Dr Mohammad Yahya Vahidi Mehrjardi, <email>mmvahidi@gmail.com</email></corresp>
</author-notes>
<pub-date pub-type="collection">
<year>2020</year>
</pub-date>
<pub-date pub-type="epub">
<day>01</day>
<month>4</month>
<year>2020</year>
</pub-date>
<volume>34</volume>
<fpage>28</fpage>
<lpage>28</lpage>
<history>
<date date-type="received">
<day>12</day>
<month>12</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>© 2020 Iran University of Medical Sciences</copyright-statement>
<copyright-year>2020</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/1.0/">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution NonCommercial-ShareAlike 1.0 License (CC BY-NC-SA 1.0), which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.</license-p>
</license>
</permissions>
<self-uri xlink:href="http://mjiri.iums.ac.ir">http://mjiri.iums.ac.ir</self-uri>
<abstract>
<p><bold>Background:</bold> Diabetes mellitus (DM) is a growing epidemic metabolic syndrome, which affects near 5.6% of the world’s population. Almost 12% of health expenditure is dedicated to this disorder. Discovering and developing biomarkers as a practical guideline with high specificity and sensitivity for the diagnosis, prognosis, and clinical management of DM is one of the subjects of great interest among DM researchers due to the long-lasting asymptomatic clinical manifestation of DM. In this study, we described a recently identified molecular biomarker involved in DM. </p>
<p><bold>Methods:</bold> This review study was done at the Diabetes Research Center affiliated to Shahid Sadoughi University of Medical Sciences. PubMed, Scopus, Google Scholar, and Web of Science were searched using the following keywords: "diabetes mellitus", "biomarker", "microRNA", "diagnostic tool" and "clinical manifestation." </p>
<p><bold>Results:</bold> A total of 107 studies were finally included in this review. After evaluating numerous articles, including original, metaanalysis, and review studies, we focused on molecular biomarkers involved in DM diagnosis and management. </p>
<p><bold>Conclusion:</bold> Increasing interest in biomarkers associated with DM goes back to its role in decreasing diabetes-related morbidity and mortality. This review focused on major molecular biomarkers such as proteomic and microRNA (miRNAs) as novel and interesting DM biomarkers that can help achieve timely diagnosis of DM.</p>
</abstract>
<kwd-group>
<kwd>Diabetes Mellitus</kwd>
<kwd>Biomarkers</kwd>
<kwd>MicroRNAs</kwd>
</kwd-group>
<counts>
<fig-count count="1"></fig-count>
<table-count count="2"></table-count>
<ref-count count="111"></ref-count>
<page-count count="8"></page-count>
</counts>
</article-meta>
<notes>
<p>
<bold><italic>Cite this article as:</italic></bold> Aghaei Zarch SM, Dehghan Tezerjani M, Talebi M, Vahidi Mehrjardi MY. Molecular biomarkers in diabetes mellitus (DM). <italic>Med J Islam Repub Iran</italic>. 2020 (1 Apr);34:28. https://doi.org/10.34171/mjiri.34.28</p>
</notes>
</front>
<body>
<boxed-text id="bx1" orientation="portrait" position="float">
<sec id="box1">
<title>↑ What is “already known” in this topic:</title>
<p>Diabetes mellitus (DM) is a progressive condition and can get
worse without treatment. DM, especially T2DM, is predictable
and preventable. Therefore, effective methods for diagnosing
prediabetes are required to reduce the risk of its progression to
diabetes. The current biomarkers such as glycated hemoglobin
(HbA1c) have moderate sensitivity and specificity and may be
inaccurate in certain clinical conditions. Therefore, combining
several biomarkers may identify those at high risk for
developing diabetes more accurately.</p>
</sec>
<sec id="box2">
<title>→ What this article adds:</title>
<p>Recent studies have suggested that the expression of biomolecules,
including microRNAs, proteins, and metabolites, specifically
change during the progression of DM, and their signature changes
with DM and its related complications. MicroRNAs (miRNAs) are
autocrine and endocrine regulators of gene expression and because
of their stability in body fluid, they can be used as noninvasive
prediction tools in DM. In this study, our aim was to summarize
biomolecules that could be potential biomarkers in DM.</p>
</sec>
</boxed-text>
<sec id="s1" sec-type="introduction">
<title>Introduction</title>
<p>
Diabetes mellitus (DM), as a progressive metabolic disorder, is a global epidemic that influences more than 350 million people around the world and has been identified as a contributing factor for morbidity and mortality. Type 2 (T2DM) and Type 1 diabetes mellitus (T1DM) are 2 major forms of DM. T1DM is characterized by self-destructive pancreatic beta cells and accounts for 5%-8% of all cases of DM. However, T2DM is the most common form of DM and occurs when the target tissue loses insulin sensitivity, including the liver, skeletal muscles, and adipose tissues (<xref ref-type="bibr" rid="R1">1</xref>). Among the diabetes complications, microvascular complications such as nephropathy, retinopathy, and cardiomy opathy are common in patients with T1DM and T2DM. Diabetic nephropathy (DN) as a major cause of renal failure is observed in 30% of T1DM patients and approximately 20% to 30% of T2DM individuals (<xref ref-type="bibr" rid="R2">2</xref>). Diabetic cardiomyopathy (DC) is characterized by cardiac remodeling and diastolic dysfunction. In addition, clinical manifestation of coronary artery and hypertension are not observed in individuals who are suffering from DM (<xref ref-type="bibr" rid="R3">3</xref>). Diabetic retinopathy (DR) is one of the most identified microvascular complications of diabetes mellitus (<xref ref-type="bibr" rid="R4">4</xref>). Approximately, one-third of diabetic individuals are suffering from diabetic retinopathy; also, proliferative diabetic retinopathy and diabetic macular edema (DME), which are vision threatening, are developed in more than 10% of the patients (<xref ref-type="bibr" rid="R5">5</xref>).</p>
<p>
A biomarker mainly refers to a characteristic that is proposed as a sign of pathogenic processes, normal biological procedures, and pharmacological responses to a therapeutic involvement (<xref ref-type="bibr" rid="R6">6</xref>). Biomarkers are divided into 2 categories: traditional and novel biomarkers. The former such as HbA1c are those well defined in research and clinical medicine, but the latter such as miRNA and some proteomic markers are not broadly used in clinical medicine(<xref ref-type="bibr" rid="R7">7</xref>).</p>
<p>
In this review, we focused on diagnostic molecular biomarkers such as proteomics and microRNAs involved in T1DM and T2DM to pinpoint new areas for further experimental studies (<xref ref-type="table" rid="T1">Tables 1</xref> and <xref ref-type="table" rid="T2">2</xref>).</p>
<table-wrap id="T1" orientation="portrait" position="float">
<label>Table 1</label>
<caption>
<title>Better characterized proteomic biomarkers involved in T1DM and T2DM
</title>
</caption>
<table frame="hsides" rules="none">
<tbody>
<tr style="border-width: 0px 0px 1pt 0px ; border-style: none none solid none">
<td colspan="1" rowspan="1">Proteomic biomarker</td>
<td colspan="1" rowspan="1">Traditional</td>
<td colspan="1" rowspan="1">Novel</td>
<td colspan="1" rowspan="1">T1DM</td>
<td colspan="1" rowspan="1">T2DM</td>
<td colspan="1" rowspan="1">Reference</td>
</tr>
<tr>
<td colspan="1" rowspan="1">GAD</td>
<td colspan="1" rowspan="1">*</td>
<td colspan="1" rowspan="1">
</td>
<td colspan="1" rowspan="1">*</td>
<td colspan="1" rowspan="1">
</td>
<td colspan="1" rowspan="1">
<xref ref-type="bibr" rid="R8">8</xref>
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">IGRP</td>
<td colspan="1" rowspan="1">*</td>
<td colspan="1" rowspan="1">
</td>
<td colspan="1" rowspan="1">*</td>
<td colspan="1" rowspan="1">
</td>
<td colspan="1" rowspan="1"><xref ref-type="bibr" rid="R10">10</xref>, <xref ref-type="bibr" rid="R26">26</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1">IA-2</td>
<td colspan="1" rowspan="1">*</td>
<td colspan="1" rowspan="1">
</td>
<td colspan="1" rowspan="1">*</td>
<td colspan="1" rowspan="1">
</td>
<td colspan="1" rowspan="1">
<xref ref-type="bibr" rid="R27">27</xref>
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">ZnT8</td>
<td colspan="1" rowspan="1">*</td>
<td colspan="1" rowspan="1">
</td>
<td colspan="1" rowspan="1">*</td>
<td colspan="1" rowspan="1">
</td>
<td colspan="1" rowspan="1">
<xref ref-type="bibr" rid="R10">10</xref>
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Insulin</td>
<td colspan="1" rowspan="1">*</td>
<td colspan="1" rowspan="1">
</td>
<td colspan="1" rowspan="1">*</td>
<td colspan="1" rowspan="1">
</td>
<td colspan="1" rowspan="1">
<xref ref-type="bibr" rid="R1">1</xref>
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">CCL3</td>
<td colspan="1" rowspan="1">
</td>
<td colspan="1" rowspan="1">*</td>
<td colspan="1" rowspan="1">*</td>
<td colspan="1" rowspan="1">
</td>
<td colspan="1" rowspan="1">
<xref ref-type="bibr" rid="R18">18</xref>
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">DOC3B</td>
<td colspan="1" rowspan="1">
</td>
<td colspan="1" rowspan="1">*</td>
<td colspan="1" rowspan="1">*</td>
<td colspan="1" rowspan="1">
</td>
<td colspan="1" rowspan="1">
<xref ref-type="bibr" rid="R20">20</xref>
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Creatinine</td>
<td colspan="1" rowspan="1">*</td>
<td colspan="1" rowspan="1">
</td>
<td colspan="1" rowspan="1">
</td>
<td colspan="1" rowspan="1">*</td>
<td colspan="1" rowspan="1">
<xref ref-type="bibr" rid="R1">1</xref>
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">IL-6</td>
<td colspan="1" rowspan="1">
</td>
<td colspan="1" rowspan="1">*</td>
<td colspan="1" rowspan="1">
</td>
<td colspan="1" rowspan="1">*</td>
<td colspan="1" rowspan="1"><xref ref-type="bibr" rid="R28">28</xref>, <xref ref-type="bibr" rid="R29">29</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1">CRP</td>
<td colspan="1" rowspan="1">
</td>
<td colspan="1" rowspan="1">*</td>
<td colspan="1" rowspan="1">
</td>
<td colspan="1" rowspan="1">*</td>
<td colspan="1" rowspan="1">
<xref ref-type="bibr" rid="R29">29</xref>
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">sOB-R</td>
<td colspan="1" rowspan="1">
</td>
<td colspan="1" rowspan="1">*</td>
<td colspan="1" rowspan="1">
</td>
<td colspan="1" rowspan="1">*</td>
<td colspan="1" rowspan="1">
<xref ref-type="bibr" rid="R30">30</xref>
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Adipokines</td>
<td colspan="1" rowspan="1">
</td>
<td colspan="1" rowspan="1">*</td>
<td colspan="1" rowspan="1">
</td>
<td colspan="1" rowspan="1">*</td>
<td colspan="1" rowspan="1"><xref ref-type="bibr" rid="R1">1</xref>, <xref ref-type="bibr" rid="R31">31</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1">c-reactive protein (CRP(</td>
<td colspan="1" rowspan="1">
</td>
<td colspan="1" rowspan="1">*</td>
<td colspan="1" rowspan="1">
</td>
<td colspan="1" rowspan="1">*</td>
<td colspan="1" rowspan="1"><xref ref-type="bibr" rid="R1">1</xref>, <xref ref-type="bibr" rid="R32">32</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1">Ferritin</td>
<td colspan="1" rowspan="1">
</td>
<td colspan="1" rowspan="1">*</td>
<td colspan="1" rowspan="1">
</td>
<td colspan="1" rowspan="1">*</td>
<td colspan="1" rowspan="1"><xref ref-type="bibr" rid="R1">1</xref>, <xref ref-type="bibr" rid="R33">33</xref>, <xref ref-type="bibr" rid="R34">34</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1">Incretins</td>
<td colspan="1" rowspan="1">
</td>
<td colspan="1" rowspan="1">*</td>
<td colspan="1" rowspan="1">
</td>
<td colspan="1" rowspan="1">*</td>
<td colspan="1" rowspan="1"><xref ref-type="bibr" rid="R1">1</xref>, <xref ref-type="bibr" rid="R35">35</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1">Cathepsin D</td>
<td colspan="1" rowspan="1">
</td>
<td colspan="1" rowspan="1">*</td>
<td colspan="1" rowspan="1">
</td>
<td colspan="1" rowspan="1">*</td>
<td colspan="1" rowspan="1"><xref ref-type="bibr" rid="R36">36</xref>, <xref ref-type="bibr" rid="R37">37</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1">NCAM.L1</td>
<td colspan="1" rowspan="1">
</td>
<td colspan="1" rowspan="1">*</td>
<td colspan="1" rowspan="1">
</td>
<td colspan="1" rowspan="1">*</td>
<td colspan="1" rowspan="1">
<xref ref-type="bibr" rid="R36">36</xref>
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Alpha1-antitrypsin</td>
<td colspan="1" rowspan="1">
</td>
<td colspan="1" rowspan="1">*</td>
<td colspan="1" rowspan="1">
</td>
<td colspan="1" rowspan="1">*</td>
<td colspan="1" rowspan="1"><xref ref-type="bibr" rid="R36">36</xref>, <xref ref-type="bibr" rid="R38">38</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1">Endocan</td>
<td colspan="1" rowspan="1">
</td>
<td colspan="1" rowspan="1">*</td>
<td colspan="1" rowspan="1">
</td>
<td colspan="1" rowspan="1">*</td>
<td colspan="1" rowspan="1"><xref ref-type="bibr" rid="R36">36</xref>, <xref ref-type="bibr" rid="R39">39</xref></td>
</tr>
</tbody>
</table>
</table-wrap>
<table-wrap id="T2" orientation="portrait" position="float">
<label>Table 2</label>
<caption>
<title>The reported miRNAs in the T2DM and T1DM and its complications
</title>
</caption>
<table frame="hsides" rules="none">
<tbody>
<tr style="border-width: 0px 0px 1pt 0px ; border-style: none none solid none">
<td colspan="1" rowspan="1">Type of miRNA</td>
<td colspan="1" rowspan="1">Biological importance</td>
<td colspan="1" rowspan="1">Source</td>
<td colspan="1" rowspan="1">Nephropathy</td>
<td colspan="1" rowspan="1">Retinopathy</td>
<td colspan="1" rowspan="1">Cardiovascular disease</td>
<td colspan="1" rowspan="1">Reference</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
<break></break>
T2DM
</td>
<td colspan="1" rowspan="1">
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">miR-21</td>
<td colspan="1" rowspan="1">Promoting fibroblast Migration and targeting SMAD7 and PTEN</td>
<td colspan="1" rowspan="1">Serum</td>
<td colspan="1" rowspan="1">*</td>
<td colspan="1" rowspan="1">*</td>
<td colspan="1" rowspan="1">*</td>
<td colspan="1" rowspan="1"><xref ref-type="bibr" rid="R57">57</xref>, <xref ref-type="bibr" rid="R82">82</xref>-<xref ref-type="bibr" rid="R86">86</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1">miR-29</td>
<td colspan="1" rowspan="1">Acting as a tumor suppressor and also engaging in apoptosis</td>
<td colspan="1" rowspan="1">Serum/urine</td>
<td colspan="1" rowspan="1">*</td>
<td colspan="1" rowspan="1">*</td>
<td colspan="1" rowspan="1">*</td>
<td colspan="1" rowspan="1"><xref ref-type="bibr" rid="R57">57</xref>, <xref ref-type="bibr" rid="R87">87</xref>-<xref ref-type="bibr" rid="R90">90</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1">miR-126</td>
<td colspan="1" rowspan="1">Playing an important role in efferocytosis by targeting ADAM-9</td>
<td colspan="1" rowspan="1">Plasma/urine</td>
<td colspan="1" rowspan="1">*</td>
<td colspan="1" rowspan="1">*</td>
<td colspan="1" rowspan="1">*</td>
<td colspan="1" rowspan="1"><xref ref-type="bibr" rid="R91">91</xref>-<xref ref-type="bibr" rid="R94">94</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1">miR-200</td>
<td colspan="1" rowspan="1">Engaging in fibrogenesis through TGF-β signaling</td>
<td colspan="1" rowspan="1">Epithelial cells/</td>
<td colspan="1" rowspan="1">*</td>
<td colspan="1" rowspan="1">*</td>
<td colspan="1" rowspan="1">*</td>
<td colspan="1" rowspan="1"><xref ref-type="bibr" rid="R95">95</xref>-<xref ref-type="bibr" rid="R99">99</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1">miR-375</td>
<td colspan="1" rowspan="1">Targeting 3’- phosphoinositide – dependent protein kinase – 1 and regulating Glucose – induced biological response in</td>
<td colspan="1" rowspan="1">Serum/blood</td>
<td colspan="1" rowspan="1">Need more experimental studies</td>
<td colspan="1" rowspan="1">*</td>
<td colspan="1" rowspan="1">*</td>
<td colspan="1" rowspan="1"><xref ref-type="bibr" rid="R100">100</xref>, <xref ref-type="bibr" rid="R101">101</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1">miR-7</td>
<td colspan="1" rowspan="1">MiR-7 plays a critical role in the proliferation of adult beta cells by targeting several components of mTOR signaling pathway.</td>
<td colspan="1" rowspan="1">Serum</td>
<td colspan="1" rowspan="1">Need more experimental studies</td>
<td colspan="1" rowspan="1">*</td>
<td colspan="1" rowspan="1">*</td>
<td colspan="1" rowspan="1"><xref ref-type="bibr" rid="R70">70</xref>, <xref ref-type="bibr" rid="R102">102</xref>-<xref ref-type="bibr" rid="R104">104</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1">miR-3666</td>
<td colspan="1" rowspan="1">By targeting adiponectin play key role in insulin secretion</td>
<td colspan="1" rowspan="1">Serum/peripheral blood</td>
<td colspan="1" rowspan="1">Need more experimental studies</td>
<td colspan="1" rowspan="1">Need more experimental studies</td>
<td colspan="1" rowspan="1">Need more experimental studies</td>
<td colspan="1" rowspan="1">
<xref ref-type="bibr" rid="R73">73</xref>
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">miR-135a</td>
<td colspan="1" rowspan="1">By suppressing Rock‐1 involved in insulin signaling pathway</td>
<td colspan="1" rowspan="1">Serum/plasma</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">Need more experimental studies</td>
<td colspan="1" rowspan="1">Need more experimental studies</td>
<td colspan="1" rowspan="1">
<xref ref-type="bibr" rid="R74">74</xref>
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
<break></break>
T1DM
</td>
<td colspan="1" rowspan="1">
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">miR-326</td>
<td colspan="1" rowspan="1">mediated TH-17 differentiation through translational inhibition of Ets-1</td>
<td colspan="1" rowspan="1">Blood</td>
<td colspan="1" rowspan="1">*</td>
<td colspan="1" rowspan="1">Need more experimental studies</td>
<td colspan="1" rowspan="1">Need more experimental studies</td>
<td colspan="1" rowspan="1"><xref ref-type="bibr" rid="R105">105</xref>, <xref ref-type="bibr" rid="R106">106</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1">miR-146</td>
<td colspan="1" rowspan="1">By targeting IRAK1 and TRAF6 modulate inflammatory response</td>
<td colspan="1" rowspan="1">PBMCs</td>
<td colspan="1" rowspan="1">*</td>
<td colspan="1" rowspan="1">*</td>
<td colspan="1" rowspan="1">*</td>
<td colspan="1" rowspan="1"><xref ref-type="bibr" rid="R107">107</xref>-<xref ref-type="bibr" rid="R110">110</xref></td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s2" sec-type="methods">
<title>Methods</title>
<p>
This narrative review study focused on molecular biomarkers with a close association with DM. A thorough literature search was done on Google, Google Scholar, and Pubmed databases using the following keywords: “diabetes mellitus”, “biomarker”, “microRNA”, “diagnostic tool”, and “clinical manifestation”. Next, after evaluating numerous articles, including original, meta-analysis, and review papers, we summarized recently reported biomarkers and their roles in the onset of DM clinical manifestation.</p>
<sec id="s2-0-1">
<title>1. Traditional proteomic biomarkers involved in T1DM</title>
<sec id="s2-0-2">
<title>1.1. Glutamic acid decarboxylase (GAD)</title>
<p>
Glutamic acid decarboxylase (GAD) as an enzyme converts glutamate to gamma-aminobutyric acid (GABA). This enzyme employs pyridoxal phosphate (PLP) as a cofactor for its activity. In addition, 2 isoforms of GAD can be seen in mammals, which are encoded by 2 distinct genes known as GAD1 and GAD2, but only GAD2 is expressed in the pancreas. Patients who are suffering from T1DM produce autoantibodies against GAD1 and GAD2 (<xref ref-type="bibr" rid="R8">8</xref>). Abnormal expression levels of the aforementioned proteins can occur in patients with T1DM and can be used as a potential biomarker for T1DM detection.</p>
</sec>
<sec id="s2-0-22">
<title>1.2. Islet-specific glucose-6-phosphatase catalytic subunit-related protein (IGRP)</title>
<p>
IGRP as a glycoprotein belongs to glucose-6-phosphatase (G6Pase) family and its expression is limited to the islet cells. G6Pase-β and G6Pase-α are well-known members of G6Pase family, among which G6Pase-β is ubiquitously expressed. Multiple helices are responsible for IGRP anchoring to endoplasmic reticulum (ER) membrane. IGRP is one of the critical factors in glycogenolysis and gluconeogenesis. Furthermore, the role of IGRP as a contributing factor in blood glucose homeostasis has also been recognized. The T1D susceptibility locus IDDM7 was mapped within the IGRP locus, which may implicate IGRP as a candidate gene in T1DM (<xref ref-type="bibr" rid="R9">9</xref>). According to the recent experiments in T1D, autoantibodies are produced against IGRP, so the expression levels of the autoantibodies can be used as a potential biomarker in T1D detection (<xref ref-type="bibr" rid="R10">10</xref>).</p>
</sec>
<sec id="s2-0-3">
<title>1.3. Tyrosine phosphatase-like protein IA-2</title>
<p>
IA-2, with 979 residues, belongs to transmembrane protein tyrosine phosphatase family and is enzymatically inactive. It has an intracellular, transmembrane, and extracellular domains, with 379, 24, and 576 residues, respectively (<xref ref-type="bibr" rid="R11">11</xref>). According to the recent studies, IA-2 is an essential part of secretory granules in neuroendocrine cells (<xref ref-type="bibr" rid="R12">12</xref>). IA-2 gene is mapped to the long arm of chromosome 2 at position 35. Also, IA-2 gene spans over 20 Kb of genomic DNA and comprises 16 exons. Moreover, it is considered as a major autoantigen in T1D. Autoantibodies to IA-2 can be used as predictive biomarkers to identify risks of developing T1D, as they appear years before the onset of T1D clinical manifestation (<xref ref-type="bibr" rid="R13">13</xref>).</p>
</sec>
<sec id="s2-0-4">
<title>1.4. Cation efflux transporter ZnT8</title>
<p>
Zinc transporter 8 (ZnT8) belongs to Cation diffusion facilitator (CDF) family of proteins and its expression is restricted to the pancreatic α- and β-cells and the kidneys (<xref ref-type="bibr" rid="R14">14</xref>). Zinc in pancreatic β-cells is transported by ZnT8 from the cytosol into the lumens of insulin granules (<xref ref-type="bibr" rid="R15">15</xref>). In addition, ZnT8 is one of the major self-antigens found in T1D patients (<xref ref-type="bibr" rid="R16">16</xref>). Hence, autoantibodies produced against this autoantigen can be used as a potential biomarker to distinguish between individuals with T1D and healthy individuals (<xref ref-type="bibr" rid="R10">10</xref>).</p>
</sec>
</sec>
<sec id="s2-0-5">
<title>2.Novel proteomic biomarker involved in T1DM</title>
<sec id="s2-0-21">
<title>2.1. CCL3</title>
<p>
Chemokines are a large family of chemoattractant cytokines for leukocytes and their receptors belong to a family of specific G-protein-coupled 7 transmembrane domain receptors. CCL3, also known as macrophage inflammatory protein-1α (MIP-1α), is a CC chemokine characterized as inducers of inflammatory process in various inflammatory autoimmune diseases. An intensive investigation done by Shehade et al disclosed that anti-CCL3 Abs were positive in nearly 87% of T1DM individuals, so anti-CCL3 Abs can be used as a powerful biomarker in T1DM (<xref ref-type="bibr" rid="R17">17</xref>-<xref ref-type="bibr" rid="R18">18</xref>).</p>
</sec>
<sec id="s2-0-20">
<title>2.2. DOC2B</title>
<p>
DOC2 family of proteins contains 3 isoforms: designated DOC2A, DOC2B, and DOC2C. DOC2B is a calcium sensor, which positively regulates SNARE-dependent fusion of insulin vesicles with membranes in pancreatic beta cells (<xref ref-type="bibr" rid="R19">19</xref>). An experimental investigation conducted by Aslamy et al in 2018 revealed that human DOC2B levels were reduced over 2-fold in platelets from new-onset T1D in humans, so DOC2B abundance may serve as an early biomarker of T1D (<xref ref-type="bibr" rid="R20">20</xref>).</p>
</sec>
</sec>
<sec id="s2-0-6">
<title>3. Traditional proteomic biomarker in T2DM</title>
<sec id="s2-0-7">
<title>3.1. CD59</title>
<p>
CD59 protein inhibits membrane attack complex formation; therefore, it prevents cell lysis. CD59 expression level is high in pancreatic β-cell and it plays a critical role in insulin secretion. In addition, its inactivation occurs in people with diabetes due to glycation (<xref ref-type="bibr" rid="R21">21</xref>). In 2013, Ghosh et al found the expression level of glycated CD59 (GCD59) as a biomarker in T2DM and revealed that this biomarker was markedly increased in DM individuals. Also, there is a positive association between this biomarker and HbA1C. This biomarker with sensitivity and specificity of 93% and 100%, respectively, can be considered as a potential biomarker to distinguish individuals with diabetes from healthy individuals (<xref ref-type="bibr" rid="R22">22</xref>).</p>
</sec>
</sec>
<sec id="s2-0-8">
<title>4. Novel proteomic biomarker in T2DM</title>
<sec id="s2-0-19">
<title>4.1.Growth-differentiation factor-15 (GDF-15)</title>
<p>
GDF-15 belongs to TGF-β superfamily and plays a critical role in growth, differentiation, and inflammatory response (<xref ref-type="bibr" rid="R23">23</xref>). GDF-15 is highly expressed in macrophages, endothelial cells, and adipocyte; and its expression level markedly increases in individuals with insulin resistance and chronic kidney diseases (<xref ref-type="bibr" rid="R24">24</xref>). Serum GDF-15 expression levels increased in individuals with T2DM; therefore, GDF-15 as a powerful tool enables us to diagnose T2DM. In addition, the increased GDF-15 expression levels is linked with increased Ang-2 expression level in diabetic patients (<xref ref-type="bibr" rid="R25">25</xref>).</p>
<p>
miRNAs are small molecules with 21 to 23 nucleotides in length that can bind to 3<sup>'</sup>-UTR region of the target molecule. MicroRNAs prevent translation by binding to their target molecules and affect approximately 30% of the coding genes (<xref ref-type="bibr" rid="R40">40</xref>). Furthermore, a large number of investigations have revealed that miRNAs dysregulation is linked with some clinical manifestations such as microvascular complications (nephropathy, retinopathy, and cardiomyopathy) involved in DM (<xref ref-type="fig" rid="F1">Fig. 1</xref>) (<xref ref-type="bibr" rid="R41">41</xref>). Abundance of miRNAs in human biofluids, including urine, serum, saliva, tears, plasma, colostrum, cerebrospinal, and seminal fluids make them a valuable biomarker for numerous disease such as DM (<xref ref-type="bibr" rid="R42">42</xref>). In this review, we provided some better characterized miRNAs involved in T1DM and T2DM and their microvascular complications.</p>
<fig id="F1" orientation="portrait" position="float">
<label>Fig. 1</label>
<graphic xlink:href="mjiri-34-28-g001"></graphic>
<statement>
<p> Major miRNAs engaged in diabetes mellitus microvascular complications</p>
</statement>
</fig>
</sec>
</sec>
<sec id="s2-0-9">
<title>5. Major microRNAs involved in T2DM</title>
<sec id="s2-0-10">
<title>5.1. miR-375</title>
<p>
miR-375 is located on human chromosome 2 in an intergenic region between the CRYBA2 and CCDC108 genes (<xref ref-type="bibr" rid="R43">43</xref>). miR-375 is considered as an essential miRNA for normal glucose homeostasis, β cell proliferation, and β and α cells turnover (<xref ref-type="bibr" rid="R44">44</xref>). Moreover, it has been identified as a pancreatic islet cell specific miRNA that targets myotrophin mRNA. Myotrophin participates actively in the fusion of secretion granules with cell membrane; thus, miR-375 can independently inhibit glucose-induced insulin secretion (<xref ref-type="bibr" rid="R45">45</xref>). Also, serum expression level of miR-375 is elevated due to chronic hyperglycemia and β cell death, so miR-375 expression level is suitable for predicting β cell death (<xref ref-type="bibr" rid="R46">46</xref>). Furthermore, miR-375 targets PDK1 in porcine pancreatic stem cells (PSCs) and if the expression level of miR-375 increases, the inhibition of PDK1-AKT signaling cascade will occur. Therefore, pancreatic stem cells (PSCs) do not differentiate into islet-like cells (<xref ref-type="bibr" rid="R47">47</xref>). Recent investigations have shown that miR-375 as a contributing factor plays an important role in 3T3-L1 adipocyte differentiation via ERK-PPARγ2-ap2 signaling pathway (<xref ref-type="bibr" rid="R48">48</xref>). An experimental study by Karolina et al in 2012 revealed that miR-375 expression levels were increased in T2DM individuals compared to healthy controls (<xref ref-type="bibr" rid="R49">49</xref>).</p>
</sec>
<sec id="s2-0-23">
<title>5.2.miR-200</title>
<p>
miR-200 family consists of 5 members whose transcripts can be seen as 2 separate polycistronic pri-miRNAs. miR200a/b and miR-429 are located in one cluster on chromosome 1, while miR-200c and miR-141 are part of another cluster on chromosome 12 (<xref ref-type="bibr" rid="R50">50</xref>). DM is characterized by Beta cell apoptosis. Thioredoxin-interacting protein (TXNIP) as a cellular redox regulator and a proapoptotic factor is the most upregulated gene in human pancreatic islets in response to glucose. TXNIP plays a critical role in apoptosis by inducing miR-200b. Consequently, miR-200b targets Zeb1 and blocks its activity, which results in β cell apoptosis (<xref ref-type="bibr" rid="R51">51</xref>). miR-200 is one of the crucial miRNAs in insulin signaling pathway that targets FOG2. miR-200 prevents disturbances in insulin signaling pathway (<xref ref-type="bibr" rid="R52">52</xref>). Furthermore, the loss of miR-200 transcripts promotes survival of β cell by downregulating Xiap, which is a potent inhibitor of caspase activation. As a result, human β cells can be protected against apoptosis by overexpression of Xiap (<xref ref-type="bibr" rid="R53">53</xref>). Therefore, miR-200 family expression alteration may be associated with T2DM (<xref ref-type="bibr" rid="R54">54</xref>).</p>
</sec>
<sec id="s2-0-11">
<title>5.3.miR-126</title>
<p>
miR-126, an intronic product of an intron of the Egfl7 gene, is located on 9q34 (<xref ref-type="bibr" rid="R55">55</xref>). Endothelial cells are rich in miR-126, which is one of the several contributing factors in vascular integrity, wound healing, and angiogenesis (<xref ref-type="bibr" rid="R56">56</xref>). In addition, miR-126 plays a critical role in efferocytosis by targeting ADAM-9.Liu et al (2014) analyzed serum miR-126 levels of diabetic's patients, prediabetics, and nondiabetic individuals as controls and found that miR-126 was significantly downregulated in diabetic patients compared with prediabetics. Their results revealed that the expression levels of miR-126 in nondiabetic controls were higher than 2 former groups. Therefore, the expression levels of miR-126 may be used as a potential distinguishing biomarker. With respect to treatment, miR-126 expression levels can also be used as a biomarker; eg, miR-126 alteration triggers T2DM clinical manifestation. Therefore, an individual with downregulated miR-126 may get diabetes within 2 years (<xref ref-type="bibr" rid="R57">57</xref>). Therefore, miR-126 expression levels can be applied for early T2DM diagnosis (<xref ref-type="bibr" rid="R58">58</xref>).</p>
</sec>
<sec id="s2-0-24">
<title>5.4.MiR-21</title>
<p>
miR-21 is a type of miRNA which is crucial in multiple biological processes such as proliferation, development, and oncology (<xref ref-type="bibr" rid="R59">59</xref>). Its gene was mapped to 17q23.2, which is located on the downstream of the the gene encoding vacuole membrane protein 1 (VMP1) (<xref ref-type="bibr" rid="R60">60</xref>). By the analysis conducted in the promoter region of miR-21 gene, numerous binding sites for transcription factors such as SRF, activation protein1 (AP1), nuclear factor1 (NF1), signal transducer, and activator of transcription3 (STAT3), C/EBP-α, and Ets/PU-1 were identified (<xref ref-type="bibr" rid="R61">61</xref>). The human miR-21 promoter retains all of these elements, and their high conservation among vertebrates suggests that highly conserved transcriptional regulatory mechanisms operate on the promoter (<xref ref-type="bibr" rid="R62">62</xref>). It was also disclosed that TGF-β1 can increase miR-21 expression levels during renal fibrosis through a Smad3-dependent mechanism (<xref ref-type="bibr" rid="R63">63</xref>). According to a study done by Zampetaki and et al in 2008, it was revealed that miR-21 expression levels were downregulated in plasma of T2DM individuals than controls (<xref ref-type="bibr" rid="R64">64</xref>).</p>
</sec>
<sec id="s2-0-12">
<title>5.5.miR-29</title>
<p>
The miR-29 family, with 4 mature members, miR-29a, miR-29b1, miR-29b2, and miR-29c, are encoded by 2 gene clusters. These miR-29s loci are found on 2 different chromosomes: miR-29b2/miR-29c on chromosome 1q32 and miR-29b1/miR-29a on chromosome 7q32. These miRNAs play an important role in the insulin signaling pathway by targeting these genes, including phosphoinositide 3-kinase (PI3K) regulatory subunit 1 (PIK3R1), insulin receptor substrate1 (IRS1), AKT2, and PI3K regulatory subunit 3 (PIK3R3) (<xref ref-type="bibr" rid="R65">65</xref>-<xref ref-type="bibr" rid="R66">66</xref>). Insulin-sensitive tissues are rich in miR-29 and elevated expression levels of miR-29 were found in rodent models of diabetes or obesity (<xref ref-type="bibr" rid="R67">67</xref>).</p>
</sec>
<sec id="s2-0-13">
<title>5.6.miR-7</title>
<p>
Human and mouse pancreatic islet cells are rich in miR-7 (<xref ref-type="bibr" rid="R68">68</xref>). miR-7 is mapped to 3 different genomic loci: 9q21, 15q26, and 19q13. The products of these 3 loci can be changed into the same mature miR-7 with 23 nucleotides (<xref ref-type="bibr" rid="R69">69</xref>). miR-7 plays a critical role in the proliferation of adult beta cells by targeting several components of mTOR signaling pathway, including TORC1, eukaryotic translation initiation factor 4E (eIF4E), P70S6K, MnK1, and Mnk2 (<xref ref-type="bibr" rid="R70">70</xref>). mTOR is an evolutionary conserved serine/threonine protein kinase that exists in 2 distinct isoforms: TORC1 and TORC2. TORC2 has a regulatory role in the cascade of insulin signaling. Wang et al indicated that miR-7 expression levels are negatively linked with beta cell proliferation; therefore, anti miR-7 oligonucleotide can be considered as a useful therapeutic tool in DM (<xref ref-type="bibr" rid="R70">70</xref>). In addition, Shujun et al found that expression levels of miR-7 are a useful biomarker for T2DM detection because its expression level is upregulated in T2DM with or without microvascular complications (<xref ref-type="bibr" rid="R71">71</xref>).</p>
</sec>
<sec id="s2-0-14">
<title>5.7.miR-3666</title>
<p>
MiR-3666 as an intronic product of FOXP2 gene is located on chromosome 7 (<xref ref-type="bibr" rid="R72">72</xref>). J. Tan et al indicated that miR-3666 plays key role in insulin secretion by targeting adiponectin in pancreatic β-cell. They showed that transfection of miR-3666 to human pancreatic β-cell line is associated with inhibition of β-cell proliferation and inducing β-cell apoptosis. Moreover, they found that miR-3666 expression levels were increased in peripheral blood of T2DM patients but were decreased in serum samples. These results highlight the crucial role of miR-3666 in T2DM pathophysiology (<xref ref-type="bibr" rid="R73">73</xref>).</p>
</sec>
<sec id="s2-0-15">
<title>5.5.miR-135a</title>
<p>
MiR-135a precursor gene (pre-miR-135a) is located within the chromosome 3 (<xref ref-type="bibr" rid="R74">74</xref>). Recently, it was identified that Rock-1 regulates insulin action via IRS-1 phosphorylation. Honardoost et al in a luciferase report assay identified Rock-1 as a direct target of miR-135a. Furthermore, transfection studies in C2C12 and L6 myoblast cell lines found a significantly lower insulin-resistence phenotype (<xref ref-type="bibr" rid="R75">75</xref>). In addition, increased expression of miR-135a in the plasma sample of newly diagnosed T2DM patients has recently been reported (<xref ref-type="bibr" rid="R76">76</xref>). These results suggest miR-135a as a desirable T2DM biomarker.</p>
</sec>
</sec>
<sec id="s2-0-16">
<title>6.Major miRNAs involved in T1DM</title>
<sec id="s2-0-17">
<title>6.1. MiR-326</title>
<p>
MiR-326 precursor gene was assigned to the chromosome 11 in the intron 1 of the beta-arrestin gene (Arrb1) (<xref ref-type="bibr" rid="R77">77</xref>). Ets-1 is considered as an essential transcription factor for the development of natural killer (NK (cells. Also, Ets-1 has been identified as a negative regulator of TH-17 differentiation (<xref ref-type="bibr" rid="R78">78</xref>). An experimental study done by DU found that miR-326 mediated TH-17 differentiation by direct targeting of Ets-1 messenger RNA (<xref ref-type="bibr" rid="R79">79</xref>).In 2011, Sebastiani et al revealed that miR-326 expression levels were upregulated in T1DM and could be used as a powerful tool for detecting T1DM (<xref ref-type="bibr" rid="R77">77</xref>).</p>
</sec>
<sec id="s2-0-18">
<title>6.2. MiR-146</title>
<p>
Two distinct forms of human miR-146 have been identified:miR-146 on chromosome 5q33 and miR-146b on chromosome 10q24 (<xref ref-type="bibr" rid="R80">80</xref>). An experimental study done by YANG et al in 2015 revealed that miR-146 expression levels were downregulated in the peripheral blood mononuclear cells (PBMC( of newly diagnosed T1DM individuals (<xref ref-type="bibr" rid="R81">81</xref>). Hence, miR-146 expression levels can be used as a valuable biomarker in T1DM.</p>
</sec>
</sec>
</sec>
<sec id="s3" sec-type="conclusion">
<title>Conclusion</title>
<p>
DM is a metabolic disorder and the number of people suffering from this syndrome is rising very fast around the world, leading to adverse health and socioeconomic impacts. The long asymptomatic period of DM provides many opportunities for disease prevention and intervention (<xref ref-type="bibr" rid="R111">111</xref>). Many studies have shown that the diagnosis of early-onset diabetes (eg, prediabetes) plays an important role in preventing its complications. Identification of new biomarkers can contribute to better understanding of pathogenesis events involved in DM and can be a powerful to detect DM in early stages. Among various biomarkers, miRNAs have been emerged as interesting tools for detecting DM. These molecules play a critical role in various cellular pathways involved in DM pathogenesis. Recent intensive studies confirmed that miRNAs may be a promising biomarker in identifying patients with DM.</p>
</sec>
<sec id="s7" sec-type="conflict of interests">
<title>Conflict of Interests</title>
<p>
The authors declare that they have no competing interests.</p>
</sec>
</body>
<back>
<ref-list>
<title>References</title>
<ref id="R1">
<label>1</label>
<element-citation publication-type="journal">
<name>
<surname>Guay</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Regazzi</surname>
<given-names>R</given-names>
</name>
<article-title>Circulating microRNAs as novel biomarkers for diabetes mellitus</article-title>
<source/>Nat Rev Endocrinol
          <year>2013</year>
<volume>9</volume>
<issue>9</issue>
<fpage>513</fpage>
<pub-id pub-id-type="pmid">23629540</pub-id>
</element-citation>
</ref>
<ref id="R2">
<label>2</label>
<element-citation publication-type="journal">
<name>
<surname>Behnam-Rassouli</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ghayour</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ghayour</surname>
<given-names>N</given-names>
</name>
<article-title>Microvascular complications of diabetes</article-title>
<source/>J Biol Sci
          <year>2010</year>
<volume>10</volume>
<issue>411</issue>
<fpage>23</fpage>
</element-citation>
</ref>
<ref id="R3">
<label>3</label>
<element-citation publication-type="journal">
<name>
<surname>León</surname>
<given-names>LE</given-names>
</name>
<name>
<surname>Rani</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Fernandez</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Larico</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Calligaris</surname>
<given-names>SD</given-names>
</name>
<article-title>Subclinical detection of diabetic cardiomyopathy with microRNAs: challenges and perspectives</article-title>
<source/>J Diabetes Res
          <year>2015</year>
<volume>2016</volume>
</element-citation>
</ref>
<ref id="R4">
<label>4</label>
<element-citation publication-type="journal">
<name>
<surname>Kaštelan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Tomić</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gverović Antunica</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Salopek Rabatić</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Ljubić</surname>
<given-names>S</given-names>
</name>
<article-title>Inflammation and pharmacological treatment in diabetic retinopathy</article-title>
<source/>Mediat Inflamm
          <year>2013</year>
<volume>2013</volume>
</element-citation>
</ref>
<ref id="R5">
<label>5</label>
<element-citation publication-type="journal">
<name>
<surname>Yau</surname>
<given-names>JW</given-names>
</name>
<name>
<surname>Rogers</surname>
<given-names>SL</given-names>
</name>
<name>
<surname>Kawasaki</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Lamourex</surname>
<given-names>EL</given-names>
</name>
<name>
<surname>Kowalski</surname>
<given-names>JW</given-names>
</name>
<name>
<surname>Bek</surname>
<given-names>T</given-names>
</name>
<etal></etal>
<article-title>Global prevalence and major risk factors of diabetic retinopathy</article-title>
<source/>Diabetes care
          <year>2012</year>
<volume>35</volume>
<issue>3</issue>
<fpage>556</fpage>
<lpage>564</lpage>
<pub-id pub-id-type="pmid">22301125</pub-id>
</element-citation>
</ref>
<ref id="R6">
<label>6</label>
<element-citation publication-type="book">
<name>
<surname>Velly</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Mohit</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Schipper</surname>
<given-names>HM</given-names>
</name>
<name>
<surname>Gornitsky</surname>
<given-names>M</given-names>
</name>
<source/>Biomarkers in Epidemiologic Research: Definition, Classification, and Implication
          <year>2017</year>
<publisher-loc>J Orofac Pain</publisher-loc>
<publisher-name>Springer</publisher-name>
<size units="page">135-139</size>
</element-citation>
</ref>
<ref id="R7">
<label>7</label>
<element-citation publication-type="journal">
<name>
<surname>Jenkins</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Joglekar</surname>
<given-names>MV</given-names>
</name>
<name>
<surname>Hardikar</surname>
<given-names>AA</given-names>
</name>
<name>
<surname>Keech</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>O'Neal</surname>
<given-names>DN</given-names>
</name>
<name>
<surname>Januszewski</surname>
<given-names>AS</given-names>
</name>
<article-title>Biomarkers in diabetic retinopathy</article-title>
<source/>Rev Diabet Stud
          <year>2015</year>
<volume>12</volume>
<issue>1-2</issue>
<fpage>159</fpage>
<pub-id pub-id-type="pmid">26676667</pub-id>
</element-citation>
</ref>
<ref id="R8">
<label>8</label>
<element-citation publication-type="journal">
<name>
<surname>Miao</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Steck</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Guyer</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Armstrong</surname>
<given-names>T</given-names>
</name>
<etal></etal>
<article-title>Electrochemiluminescence assays for insulin and glutamic acid decarboxylase autoantibodies improve prediction of type 1 diabetes risk</article-title>
<source/>Diabetes Technol The
          <year>2015</year>
<volume>17</volume>
<issue>2</issue>
<fpage>119</fpage>
<lpage>127</lpage>
</element-citation>
</ref>
<ref id="R9">
<label>9</label>
<element-citation publication-type="journal">
<name>
<surname>Dehghan Tezerjani</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Vahidi Mehrjardi</surname>
<given-names>MY</given-names>
</name>
<name>
<surname>Kalantar</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Dehghani</surname>
<given-names>M</given-names>
</name>
<article-title>Genetic Susceptibility to Transient and Permanent Neonatal Diabetes Mellitus</article-title>
<source/>Int J Pediatr
          <year>2015</year>
<volume>3</volume>
<issue>6. 1</issue>
<fpage>1073</fpage>
<lpage>1081</lpage>
</element-citation>
</ref>
<ref id="R10">
<label>10</label>
<element-citation publication-type="journal">
<name>
<surname>Roep</surname>
<given-names>BO</given-names>
</name>
<name>
<surname>Peakman</surname>
<given-names>M</given-names>
</name>
<article-title>Antigen targets of type 1 diabetes autoimmunity</article-title>
<source/>Csh Perspect Med
          <year>2012</year>
<volume>2</volume>
<issue>4</issue>
<fpage>a007781</fpage>
</element-citation>
</ref>
<ref id="R11">
<label>11</label>
<element-citation publication-type="journal">
<name>
<surname>Guerra</surname>
<given-names>LL</given-names>
</name>
<name>
<surname>Faccinetti</surname>
<given-names>NI</given-names>
</name>
<name>
<surname>Trabucchi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Rovitto</surname>
<given-names>BD</given-names>
</name>
<name>
<surname>Sabljic</surname>
<given-names>AV</given-names>
</name>
<name>
<surname>Poskus</surname>
<given-names>E</given-names>
</name>
<etal></etal>
<article-title>Novel prokaryotic expression of thioredoxin-fused insulinoma associated protein tyrosine phosphatase 2 (IA-2), its characterization and immunodiagnostic application</article-title>
<source/>BMC Biotechnol
          <year>2016</year>
<volume>16</volume>
<issue>1</issue>
<fpage>84</fpage>
<pub-id pub-id-type="pmid">27881117</pub-id>
</element-citation>
</ref>
<ref id="R12">
<label>12</label>
<element-citation publication-type="journal">
<name>
<surname>Cai</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Notkins</surname>
<given-names>AL</given-names>
</name>
<article-title>Pathophysiologic changes in IA-2/IA-2β null mice are secondary to alterations in the secretion of hormones and neurotransmitters</article-title>
<source/>Acta Diabetol
          <year>2016</year>
<volume>53</volume>
<issue>1</issue>
<fpage>7</fpage>
<lpage>12</lpage>
<pub-id pub-id-type="pmid">25861885</pub-id>
</element-citation>
</ref>
<ref id="R13">
<label>13</label>
<element-citation publication-type="journal">
<name>
<surname>Acevedo-Calado</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Pietropaolo</surname>
<given-names>SL</given-names>
</name>
<name>
<surname>Morran</surname>
<given-names>MP</given-names>
</name>
<name>
<surname>Schnell</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Vonberg</surname>
<given-names>AD</given-names>
</name>
<name>
<surname>Verge</surname>
<given-names>CF</given-names>
</name>
<etal></etal>
<article-title>Autoantibodies Directed to a Novel IA-2 Variant Protein Enhance Prediction of Type 1 Diabetes</article-title>
<source/>Diabetes
          <year>2019</year>
<fpage>db181351</fpage>
</element-citation>
</ref>
<ref id="R14">
<label>14</label>
<element-citation publication-type="journal">
<name>
<surname>Yang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Cui</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Yao</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>P</given-names>
</name>
<etal></etal>
<article-title>Gene profile identifies zinc transporters differentially expressed in normal human organs and human pancreatic cancer Curr Mol</article-title>
<source/>Med
          <year>2013</year>
<volume>13</volume>
<issue>3</issue>
<fpage>401</fpage>
<lpage>409</lpage>
</element-citation>
</ref>
<ref id="R15">
<label>15</label>
<element-citation publication-type="journal">
<name>
<surname>Chimienti</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Favier</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Seve</surname>
<given-names>M</given-names>
</name>
<article-title>ZnT-8, a pancreatic beta-cell-specific zinc transporter</article-title>
<source/>Biometals
          <year>2005</year>
<volume>18</volume>
<issue>4</issue>
<fpage>313</fpage>
<lpage>317</lpage>
<pub-id pub-id-type="pmid">16158222</pub-id>
</element-citation>
</ref>
<ref id="R16">
<label>16</label>
<element-citation publication-type="journal">
<name>
<surname>Huang</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Merriman</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Fu</surname>
<given-names>D</given-names>
</name>
<article-title>Coupling of insulin secretion and display of a granule-resident zinc transporter ZnT8 on the surface of pancreatic beta cells</article-title>
<source/>J BIOL CHEM
          <year>2017</year>
<volume>292</volume>
<issue>10</issue>
<fpage>4034</fpage>
<lpage>4043</lpage>
<pub-id pub-id-type="pmid">28130446</pub-id>
</element-citation>
</ref>
<ref id="R17">
<label>17</label>
<element-citation publication-type="book">
<name>
<surname>Islam</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Medoff</surname>
<given-names>BD</given-names>
</name>
<name>
<surname>Luster</surname>
<given-names>AD</given-names>
</name>
<source/>Chemokine and chemokine receptor analysis
          <year>2016</year>
<publisher-loc>Manual of Molecular and Clinical Laboratory Immunology, Eighth Edition</publisher-loc>
<publisher-name>American Society of Microbiology</publisher-name>
<size units="page">343-356</size>
</element-citation>
</ref>
<ref id="R18">
<label>18</label>
<element-citation publication-type="journal">
<name>
<surname>Shehadeh</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Pollack</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Wildbaum G Yaniv</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Shafat</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Makhoul</surname>
<given-names>R</given-names>
</name>
<etal></etal>
<article-title>Selective autoantibody production against CCL3 is associated with human type 1 diabetes mellitus and serves as a novel biomarker for its diagnosis J</article-title>
<source/>Immunol
          <year>2009</year>
<volume>182</volume>
<issue>12</issue>
<fpage>8104</fpage>
<lpage>8109</lpage>
</element-citation>
</ref>
<ref id="R19">
<label>19</label>
<element-citation publication-type="journal">
<name>
<surname>Houy</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Groffen</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Ziomkiewicz</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Verhage</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Pinheiro</surname>
<given-names>PS</given-names>
</name>
<name>
<surname>Sørensen</surname>
<given-names>JB</given-names>
</name>
<article-title>Doc2B acts as a calcium sensor for vesicle priming requiring synaptotagmin-1, Munc13-2 and SNAREs</article-title>
<source/>Elife
          <year>2017</year>
<volume>6</volume>
<fpage>e27000</fpage>
<pub-id pub-id-type="pmid">29274147</pub-id>
</element-citation>
</ref>
<ref id="R20">
<label>20</label>
<element-citation publication-type="journal">
<name>
<surname>Aslamy</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Oh</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Ahn</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Moin</surname>
<given-names>ASM</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Duncan</surname>
<given-names>M</given-names>
</name>
<etal></etal>
<article-title>Exocytosis Protein DOC2B as a Biomarker of Type 1 Diabetes</article-title>
<source/>J Clin Endocrinol Metab
          <year>2018</year>
<volume>103</volume>
<issue>5</issue>
<fpage>1966</fpage>
<lpage>1976</lpage>
<pub-id pub-id-type="pmid">29506054</pub-id>
</element-citation>
</ref>
<ref id="R21">
<label>21</label>
<mixed-citation publication-type="other">
Rosberg R. Novel insights of intracellular complement in pancreatic β-cell physiology. 2017.
</mixed-citation>
</ref>
<ref id="R22">
<label>22</label>
<element-citation publication-type="journal">
<name>
<surname>Ghosh</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Banik</surname>
<given-names>GD</given-names>
</name>
<name>
<surname>Maity</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Som</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Chakraborty</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Selvan</surname>
<given-names>C</given-names>
</name>
<etal></etal>
<article-title>Oxygen-18 isotope of breath CO2 linking to erythrocytes carbonic anhydrase activity: a biomarker for pre-diabetes and type 2 diabetes Sci</article-title>
<source/>Rep
          <year>2015</year>
<volume>5</volume>
</element-citation>
</ref>
<ref id="R23">
<label>23</label>
<element-citation publication-type="journal">
<name>
<surname>Fang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Gu</surname>
<given-names>C</given-names>
</name>
<article-title>GDF-15: A Multifunctional Modulator and Potential Therapeutic Target in Cancer Curr</article-title>
<source/>Pharm
          <year>2019</year>
<volume>25</volume>
<issue>6</issue>
<fpage>654</fpage>
<lpage>662</lpage>
</element-citation>
</ref>
<ref id="R24">
<label>24</label>
<element-citation publication-type="journal">
<name>
<surname>Adela</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Banerjee</surname>
<given-names>SK</given-names>
</name>
<article-title>GDF-15 as a target and biomarker for diabetes and cardiovascular diseases: a translational prospective</article-title>
<source/>J Diabetes Res
          <year>2015</year>
<volume>2015</volume>
</element-citation>
</ref>
<ref id="R25">
<label>25</label>
<element-citation publication-type="journal">
<name>
<surname>Adela</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Mohammed</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Kanwal</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Vishwakarma</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Chander Reddy</surname>
<given-names>PN</given-names>
</name>
<name>
<surname>Banerjee</surname>
<given-names>SK</given-names>
</name>
<article-title>Elevated levels of GDF-15 is associated with increased angiotensin II in hypertensive patients with Type 2 diabetes Pers</article-title>
<source/>Med
          <year>2016</year>
<volume>13</volume>
<issue>4</issue>
<fpage>325</fpage>
<lpage>336</lpage>
</element-citation>
</ref>
<ref id="R26">
<label>26</label>
<element-citation publication-type="journal">
<name>
<surname>Labaer</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Qiu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Bian</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Schatz</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Wasserfall</surname>
<given-names>CH</given-names>
</name>
<name>
<surname>Atkinson</surname>
<given-names>MA</given-names>
</name>
<article-title>Type 1 Diabetes Biomarkers</article-title>
<source/>Google Patents
          <year>2016</year>
</element-citation>
</ref>
<ref id="R27">
<label>27</label>
<element-citation publication-type="journal">
<name>
<surname>Saeki</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kubosaki</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Lan</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Notkins</surname>
<given-names>AL</given-names>
</name>
<article-title>Targeted disruption of the protein tyrosine phosphatase-like molecule IA-2 results in alterations in glucose tolerance tests and insulin secretion</article-title>
<source/>Diabetes
          <year>2002</year>
<volume>51</volume>
<issue>6</issue>
<fpage>1842</fpage>
<lpage>1850</lpage>
<pub-id pub-id-type="pmid">12031972</pub-id>
</element-citation>
</ref>
<ref id="R28">
<label>28</label>
<element-citation publication-type="journal">
<name>
<surname>Gomes</surname>
<given-names>KB</given-names>
</name>
<article-title>IL-6 and type 1 diabetes mellitus: T cell responses and increase in IL-6 receptor surface expression</article-title>
<source/>Ann Transl Med
          <year>2017</year>
<volume>5</volume>
<issue>1</issue>
</element-citation>
</ref>
<ref id="R29">
<label>29</label>
<element-citation publication-type="journal">
<name>
<surname>Tangvarasittichai</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Pongthaisong</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Tangvarasittichai</surname>
<given-names>O</given-names>
</name>
<article-title>Tumor necrosis factor-Α, interleukin-6, C-reactive protein levels and insulin resistance associated with type 2 diabetes in abdominal obesity women</article-title>
<source/>Indian J Clin Biochem
          <year>2016</year>
<volume>31</volume>
<issue>1</issue>
<fpage>68</fpage>
<lpage>74</lpage>
<pub-id pub-id-type="pmid">26855490</pub-id>
</element-citation>
</ref>
<ref id="R30">
<label>30</label>
<element-citation publication-type="journal">
<name>
<surname>Sun</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>van Dam</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Meigs</surname>
<given-names>JB</given-names>
</name>
<name>
<surname>Franco</surname>
<given-names>OH</given-names>
</name>
<name>
<surname>Mantzoros</surname>
<given-names>CS</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>FB</given-names>
</name>
<article-title>Leptin and soluble leptin receptor levels in plasma and risk of type 2 diabetes in US women: a prospective study</article-title>
<source/>Diabetes
          <year>2010</year>
<volume>59</volume>
<issue>3</issue>
<fpage>611</fpage>
<lpage>618</lpage>
<pub-id pub-id-type="pmid">19959759</pub-id>
</element-citation>
</ref>
<ref id="R31">
<label>31</label>
<element-citation publication-type="journal">
<name>
<surname>Catalina</surname>
<given-names>MO-S</given-names>
</name>
<name>
<surname>Redondo</surname>
<given-names>PC</given-names>
</name>
<name>
<surname>Granados</surname>
<given-names>MP</given-names>
</name>
<name>
<surname>Contonero</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Sanchez-Collado</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Albarran</surname>
<given-names>L</given-names>
</name>
<etal></etal>
<article-title>New insights into adipokines as potential biomarkers for type-2 diabetes mellitus</article-title>
<source/>Curr Med Chem
          <year>2019</year>
</element-citation>
</ref>
<ref id="R32">
<label>32</label>
<element-citation publication-type="journal">
<name>
<surname>Parrinello</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Lutsey</surname>
<given-names>PL</given-names>
</name>
<name>
<surname>Ballantyne</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Folsom</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>Pankow</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Selvin</surname>
<given-names>E</given-names>
</name>
<article-title>Six-year change in high-sensitivity C-reactive protein and risk of diabetes, cardiovascular disease, and mortality</article-title>
<source/>Am Heart J
          <year>2015</year>
<volume>170</volume>
<issue>2</issue>
<fpage>380</fpage>
<lpage>389 e384</lpage>
<pub-id pub-id-type="pmid">26299237</pub-id>
</element-citation>
</ref>
<ref id="R33">
<label>33</label>
<element-citation publication-type="journal">
<name>
<surname>Andrews</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Leiva</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Arredondo-Olguín</surname>
<given-names>M</given-names>
</name>
<article-title>Short repeats in the heme oxygenase 1 gene promoter is associated with increased levels of inflammation, ferritin and higher risk of type-2 diabetes mellitus</article-title>
<source/>J Trace Elem Med Biol
          <year>2016</year>
<volume>37</volume>
<fpage>25</fpage>
<lpage>30</lpage>
<pub-id pub-id-type="pmid">27473828</pub-id>
</element-citation>
</ref>
<ref id="R34">
<label>34</label>
<element-citation publication-type="journal">
<name>
<surname>Sharma</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Agrawal</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Meena</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Uradiya</surname>
<given-names>I</given-names>
</name>
<article-title>Correlation of Serum Ferritin with Insulin Resistance in Type 2 Diabetes Mellitus Patients and its Relationship with Components of Metabolic Syndrome</article-title>
<source/>J Indian Acad Clin Med
          <year>2018</year>
<volume>19</volume>
<issue>2</issue>
<fpage>97</fpage>
</element-citation>
</ref>
<ref id="R35">
<label>35</label>
<element-citation publication-type="journal">
<name>
<surname>Holst</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Vilsbøll</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Deacon</surname>
<given-names>CF</given-names>
</name>
<article-title>The incretin system and its role in type 2 diabetes mellitus</article-title>
<source/>Mol Cell Endocrinol
          <year>2009</year>
<volume>297</volume>
<issue>1-2</issue>
<fpage>127</fpage>
<lpage>136</lpage>
<pub-id pub-id-type="pmid">18786605</pub-id>
</element-citation>
</ref>
<ref id="R36">
<label>36</label>
<element-citation publication-type="journal">
<name>
<surname>Belongie</surname>
<given-names>KJ</given-names>
</name>
<name>
<surname>Ferrannini</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Johnson</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Andrade-Gordon</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Hansen</surname>
<given-names>MK</given-names>
</name>
<name>
<surname>Petrie</surname>
<given-names>JR</given-names>
</name>
<article-title>Identification of novel biomarkers to monitor β-cell function and enable early detection of type 2 diabetes risk</article-title>
<source/>PloS one
          <year>2017</year>
<volume>12</volume>
<issue>8</issue>
<fpage>e0182932</fpage>
<pub-id pub-id-type="pmid">28846711</pub-id>
</element-citation>
</ref>
<ref id="R37">
<label>37</label>
<element-citation publication-type="journal">
<name>
<surname>Reddy</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Amutha</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Rajalakshmi</surname>
<given-names>R</given-names>
</name>
<etal></etal>
<article-title>Association of increased levels of MCP-1 and cathepsin-D in young onset type 2 diabetes patients (T2DM-Y) with severity of diabetic retinopathy</article-title>
<source/>J Diabetes Complications
          <year>2017</year>
<volume>31</volume>
<issue>5</issue>
<fpage>804</fpage>
<lpage>809</lpage>
<pub-id pub-id-type="pmid">28336215</pub-id>
</element-citation>
</ref>
<ref id="R38">
<label>38</label>
<element-citation publication-type="journal">
<name>
<surname>Sandström</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Ohlsson</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Melander</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Westin</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Mahadeva</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Janciauskiene</surname>
<given-names>S</given-names>
</name>
<article-title>An association between Type 2 diabetes and α1‐antitrypsin deficiency</article-title>
<source/>Diabet Med
          <year>2008</year>
<volume>25</volume>
<issue>11</issue>
<fpage>1370</fpage>
<lpage>1373</lpage>
<pub-id pub-id-type="pmid">19046232</pub-id>
</element-citation>
</ref>
<ref id="R39">
<label>39</label>
<element-citation publication-type="journal">
<name>
<surname>Bilir</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Ekiz Bilir</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Yilmaz</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Soysal Atile</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Yildirim</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Kara</surname>
<given-names>SP</given-names>
</name>
<etal></etal>
<article-title>Association of apelin, endoglin and endocan with diabetic peripheral neuropathy in type 2 diabetic patients</article-title>
<source/>Eur Rev Med Pharmacol Sci
          <year>2016</year>
<volume>20</volume>
<issue>5</issue>
<fpage>892</fpage>
<lpage>898</lpage>
<pub-id pub-id-type="pmid">27010147</pub-id>
</element-citation>
</ref>
<ref id="R40">
<label>40</label>
<element-citation publication-type="journal">
<name>
<surname>Taylor</surname>
<given-names>DD</given-names>
</name>
<name>
<surname>Gercel-Taylor</surname>
<given-names>C</given-names>
</name>
<article-title>MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer Gynecol</article-title>
<source/>Oncol
          <year>2008</year>
<volume>110</volume>
<issue>1</issue>
<fpage>13</fpage>
<lpage>21</lpage>
</element-citation>
</ref>
<ref id="R41">
<label>41</label>
<element-citation publication-type="journal">
<name>
<surname>Lai</surname>
<given-names>EC</given-names>
</name>
<article-title>Two decades of miRNA biology: lessons and challenges</article-title>
<source/>RNA
          <year>2015</year>
<volume>21</volume>
<issue>4</issue>
<fpage>675</fpage>
<lpage>677</lpage>
<pub-id pub-id-type="pmid">25780186</pub-id>
</element-citation>
</ref>
<ref id="R42">
<label>42</label>
<element-citation publication-type="journal">
<name>
<surname>Deiuliis</surname>
<given-names>J</given-names>
</name>
<article-title>MicroRNAs as regulators of metabolic disease: pathophysiologic significance and emerging role as biomarkers and therapeutics</article-title>
<source/>Int J Obes
          <year>2016</year>
<volume>40</volume>
<issue>1</issue>
<fpage>88</fpage>
</element-citation>
</ref>
<ref id="R43">
<label>43</label>
<element-citation publication-type="journal">
<name>
<surname>Chakraborty</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Doss</surname>
<given-names>CGP</given-names>
</name>
<name>
<surname>Bandyopadhyay</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Agoramoorthy</surname>
<given-names>G</given-names>
</name>
<article-title>Influence of miRNA in insulin signaling pathway and insulin resistance: micro‐molecules with a major role in type‐2 diabetes</article-title>
<source/>WIRES RNA
          <year>2014</year>
<volume>5</volume>
<issue>5</issue>
<fpage>697</fpage>
<lpage>712</lpage>
<pub-id pub-id-type="pmid">24944010</pub-id>
</element-citation>
</ref>
<ref id="R44">
<label>44</label>
<element-citation publication-type="journal">
<name>
<surname>Banerjee</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Nema</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Dhas</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Mishra</surname>
<given-names>N</given-names>
</name>
<article-title>Role of MicroRNAs in type 2 diabetes and associated vascular complications</article-title>
<source/>Biochimie
          <year>2017</year>
</element-citation>
</ref>
<ref id="R45">
<label>45</label>
<element-citation publication-type="journal">
<name>
<surname>Ghelani</surname>
<given-names>HS</given-names>
</name>
<name>
<surname>Rachchh</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Gokani</surname>
<given-names>RH</given-names>
</name>
<article-title>MicroRNAs as newer therapeutic targets: A big hope from a tiny player</article-title>
<source/>J Pharmacol Pharmacother
          <year>2012</year>
<volume>3</volume>
<issue>3</issue>
<fpage>217</fpage>
<pub-id pub-id-type="pmid">23129956</pub-id>
</element-citation>
</ref>
<ref id="R46">
<label>46</label>
<element-citation publication-type="journal">
<name>
<surname>Feng</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Xing</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>L</given-names>
</name>
<article-title>Regulatory roles of microRNAs in diabetes</article-title>
<source/>Int J Mol Sci
          <year>2016</year>
<volume>17</volume>
<issue>10</issue>
<fpage>1729</fpage>
</element-citation>
</ref>
<ref id="R47">
<label>47</label>
<element-citation publication-type="journal">
<name>
<surname>Hu</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Ren</surname>
<given-names>L</given-names>
</name>
<name>
<surname>He</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Hua</surname>
<given-names>J</given-names>
</name>
<etal></etal>
<article-title>miR‐375 controls porcine pancreatic stem cell fate by targeting 3‐phosphoinositide–dependent protein kinase‐1 (Pdk1)</article-title>
<source/>Cell Prolif
          <year>2016</year>
<volume>49</volume>
<issue>3</issue>
<fpage>395</fpage>
<lpage>406</lpage>
<pub-id pub-id-type="pmid">27218665</pub-id>
</element-citation>
</ref>
<ref id="R48">
<label>48</label>
<element-citation publication-type="journal">
<name>
<surname>Ling</surname>
<given-names>HY</given-names>
</name>
<name>
<surname>Wen</surname>
<given-names>GB</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>SD</given-names>
</name>
<name>
<surname>Tuo</surname>
<given-names>QH</given-names>
</name>
<name>
<surname>Ou</surname>
<given-names>HS</given-names>
</name>
<name>
<surname>Yao</surname>
<given-names>CH</given-names>
</name>
<etal></etal>
<article-title>MicroRNA‐375 promotes 3T3‐L1 adipocyte differentiation through modulation of extracellular signal‐regulated kinase signalling</article-title>
<source/>Clin Exp Pharmacol Physiol
          <year>2011</year>
<volume>38</volume>
<issue>4</issue>
<fpage>239</fpage>
<lpage>246</lpage>
<pub-id pub-id-type="pmid">21291493</pub-id>
</element-citation>
</ref>
<ref id="R49">
<label>49</label>
<element-citation publication-type="journal">
<name>
<surname>Karolina</surname>
<given-names>DS</given-names>
</name>
<name>
<surname>Tavintharan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Armugam</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sepramaniam</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Pek</surname>
<given-names>SLT</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>MTK</given-names>
</name>
<etal></etal>
<article-title>Circulating miRNA profiles in patients with metabolic syndrome</article-title>
<source/>J Clin Endocrinol Metab
          <year>2012</year>
<volume>97</volume>
<issue>12</issue>
<fpage>E2271</fpage>
<lpage>E2276</lpage>
<pub-id pub-id-type="pmid">23032062</pub-id>
</element-citation>
</ref>
<ref id="R50">
<label>50</label>
<element-citation publication-type="journal">
<name>
<surname>Magenta</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ciarapica</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Capogrossi</surname>
<given-names>MC</given-names>
</name>
<article-title>The Emerging Role of miR-200 Family in Cardiovascular Diseases</article-title>
<source/>Circ Res
          <year>2017</year>
<volume>120</volume>
<issue>9</issue>
<fpage>1399</fpage>
<lpage>1402</lpage>
<pub-id pub-id-type="pmid">28450364</pub-id>
</element-citation>
</ref>
<ref id="R51">
<label>51</label>
<element-citation publication-type="journal">
<name>
<surname>Filios</surname>
<given-names>SR</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Hong</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Jing</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Shalev</surname>
<given-names>A</given-names>
</name>
<article-title>MicroRNA-200 is induced by thioredoxin-interacting protein and regulates Zeb1 protein signaling and beta cell apoptosis</article-title>
<source/>J Biol Chem
          <year>2014</year>
<volume>289</volume>
<issue>52</issue>
<fpage>36275</fpage>
<lpage>36283</lpage>
<pub-id pub-id-type="pmid">25391656</pub-id>
</element-citation>
</ref>
<ref id="R52">
<label>52</label>
<element-citation publication-type="journal">
<name>
<surname>Dou</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Jiao</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>D</given-names>
</name>
<etal></etal>
<article-title>miR-200s contribute to interleukin-6 (IL-6)-induced insulin resistance in hepatocytes</article-title>
<source/>J Biol Chem
          <year>2013</year>
<volume>288</volume>
<issue>31</issue>
<fpage>22596</fpage>
<lpage>22606</lpage>
<pub-id pub-id-type="pmid">23798681</pub-id>
</element-citation>
</ref>
<ref id="R53">
<label>53</label>
<element-citation publication-type="journal">
<name>
<surname>Zhu</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Zhi</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J</given-names>
</name>
<etal></etal>
<article-title>miR-200bc/429 cluster modulates multidrug resistance of human cancer cell lines by targeting BCL2 and XIAP</article-title>
<source/>Cancer Chemother Pharmacol
          <year>2012</year>
<volume>69</volume>
<issue>3</issue>
<fpage>723</fpage>
<lpage>731</lpage>
<pub-id pub-id-type="pmid">21993663</pub-id>
</element-citation>
</ref>
<ref id="R54">
<label>54</label>
<element-citation publication-type="journal">
<name>
<surname>Belgardt</surname>
<given-names>B-F</given-names>
</name>
<name>
<surname>Ahmed</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Spranger</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Latreille</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Denzler</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Kondratiuk</surname>
<given-names>N</given-names>
</name>
<etal></etal>
<article-title>The microRNA-200 family regulates pancreatic beta cell survival in type 2 diabetes</article-title>
<source/>Nat Med
          <year>2015</year>
<volume>21</volume>
<issue>6</issue>
<fpage>619</fpage>
<pub-id pub-id-type="pmid">25985365</pub-id>
</element-citation>
</ref>
<ref id="R55">
<label>55</label>
<element-citation publication-type="journal">
<name>
<surname>Musiyenko</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bitko</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Barik</surname>
<given-names>S</given-names>
</name>
<article-title>Ectopic expression of miR-126*, an intronic product of the vascular endothelial EGF-like 7 gene, regulates prostein translation and invasiveness of prostate cancer LNCaP cells</article-title>
<source/>J Mol Med
          <year>2008</year>
<volume>86</volume>
<issue>3</issue>
<fpage>313</fpage>
<lpage>322</lpage>
<pub-id pub-id-type="pmid">18193184</pub-id>
</element-citation>
</ref>
<ref id="R56">
<label>56</label>
<element-citation publication-type="journal">
<name>
<surname>Fish</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Santoro</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Morton</surname>
<given-names>SU</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Yeh</surname>
<given-names>RF</given-names>
</name>
<name>
<surname>Wythe</surname>
<given-names>JD</given-names>
</name>
<etal></etal>
<article-title>miR-126 regulates angiogenic signaling and vascular integrity</article-title>
<source/>Dev Cell
          <year>2008</year>
<volume>15</volume>
<issue>2</issue>
<fpage>272</fpage>
<lpage>284</lpage>
<pub-id pub-id-type="pmid">18694566</pub-id>
</element-citation>
</ref>
<ref id="R57">
<label>57</label>
<element-citation publication-type="journal">
<name>
<surname>Qing</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Yun</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Hui</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Mao</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Wen</surname>
<given-names>F</given-names>
</name>
<etal></etal>
<article-title>Serum miRNA biomarkers serve as a fingerprint for proliferative diabetic retinopathy</article-title>
<source/>Cell Physiol Biochem
          <year>2014</year>
<volume>34</volume>
<issue>5</issue>
<fpage>1733</fpage>
<lpage>1740</lpage>
<pub-id pub-id-type="pmid">25427542</pub-id>
</element-citation>
</ref>
<ref id="R58">
<label>58</label>
<element-citation publication-type="journal">
<name>
<surname>Yan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Di</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X</given-names>
</name>
<etal></etal>
<article-title>Differential expression of microRNAs in plasma of patients with prediabetes and newly diagnosed type 2 diabetes</article-title>
<source/>Acta Diabetol
          <year>2016</year>
<volume>53</volume>
<issue>5</issue>
<fpage>693</fpage>
<lpage>702</lpage>
<pub-id pub-id-type="pmid">27039347</pub-id>
</element-citation>
</ref>
<ref id="R59">
<label>59</label>
<element-citation publication-type="journal">
<name>
<surname>Talotta</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Cimmino</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Matarazzo</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Casalino</surname>
<given-names>L</given-names>
</name>
<name>
<surname>D'Esposito</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Di Lauro</surname>
<given-names>R</given-names>
</name>
<etal></etal>
<article-title>An autoregulatory loop mediated by miR-21 and PDCD4 controls the AP-1 activity in RAS transformation</article-title>
<source/>Oncogene
          <year>2009</year>
<volume>28</volume>
<issue>1</issue>
<fpage>73</fpage>
<pub-id pub-id-type="pmid">18850008</pub-id>
</element-citation>
</ref>
<ref id="R60">
<label>60</label>
<element-citation publication-type="journal">
<name>
<surname>Sekar</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Islam</surname>
<given-names>VIH</given-names>
</name>
<name>
<surname>Thirugnanasambantham</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Saravanan</surname>
<given-names>S</given-names>
</name>
<article-title>Relevance of miR-21 in HIV and non-HIV-related lymphomas</article-title>
<source/>Tumour Biol
          <year>2014</year>
<volume>35</volume>
<issue>9</issue>
<fpage>8387</fpage>
<lpage>8393</lpage>
<pub-id pub-id-type="pmid">24961346</pub-id>
</element-citation>
</ref>
<ref id="R61">
<label>61</label>
<element-citation publication-type="journal">
<name>
<surname>Fujita</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ito</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Mizutani</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Minoguchi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Yamamichi</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Sakurai</surname>
<given-names>K</given-names>
</name>
<etal></etal>
<article-title>miR-21 Gene expression triggered by AP-1 is sustained through a double-negative feedback mechanism J Mol</article-title>
<source/>Biol
          <year>2008</year>
<volume>378</volume>
<issue>3</issue>
<fpage>492</fpage>
<lpage>504</lpage>
</element-citation>
</ref>
<ref id="R62">
<label>62</label>
<element-citation publication-type="journal">
<name>
<surname>Krichevsky</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Gabriely</surname>
<given-names>G</given-names>
</name>
<article-title>miR‐21: a small multi‐faceted RNA</article-title>
<source/>J Cell Mol Med
          <year>2009</year>
<volume>13</volume>
<issue>1</issue>
<fpage>39</fpage>
<lpage>53</lpage>
<pub-id pub-id-type="pmid">19175699</pub-id>
</element-citation>
</ref>
<ref id="R63">
<label>63</label>
<element-citation publication-type="journal">
<name>
<surname>Loboda</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sobczak</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Jozkowicz</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Dulak</surname>
<given-names>J</given-names>
</name>
<article-title>TGF-β1/Smads and miR-21 in renal fibrosis and inflammation</article-title>
<source/>Mediators Inflamm
          <year>2016</year>
<volume>2016</volume>
</element-citation>
</ref>
<ref id="R64">
<label>64</label>
<element-citation publication-type="journal">
<name>
<surname>Pescador</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Pérez-Barba</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ibarra</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Corbatón</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Martínez-Larrad</surname>
<given-names>MT</given-names>
</name>
<name>
<surname>Serrano-Ríos</surname>
<given-names>M</given-names>
</name>
<article-title>Serum circulating microRNA profiling for identification of potential type 2 diabetes and obesity biomarkers</article-title>
<source/>PloS One
          <year>2013</year>
<volume>8</volume>
<issue>10</issue>
<fpage>e77251</fpage>
<pub-id pub-id-type="pmid">24204780</pub-id>
</element-citation>
</ref>
<ref id="R65">
<label>65</label>
<element-citation publication-type="journal">
<name>
<surname>Massart</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Sjögren</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Lundell</surname>
<given-names>LS</given-names>
</name>
<name>
<surname>Mudry</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Franck</surname>
<given-names>N</given-names>
</name>
<name>
<surname>O’Gorman</surname>
<given-names>DJ</given-names>
</name>
<etal></etal>
<article-title>Altered miRNA-29 Expression in Type 2 Diabetes Influences Glucose and Lipid Metabolism in Skeletal Muscle</article-title>
<source/>Diabetes
          <year>2017</year>
<fpage>db170141</fpage>
</element-citation>
</ref>
<ref id="R66">
<label>66</label>
<element-citation publication-type="journal">
<name>
<surname>Mazzoccoli</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Robaina</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Apa</surname>
<given-names>AG</given-names>
</name>
<name>
<surname>Bonamino</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Pinto</surname>
<given-names>LW</given-names>
</name>
<name>
<surname>Queiroga</surname>
<given-names>E</given-names>
</name>
<etal></etal>
<article-title>MiR-29 silencing modulates the expression of target genes related to proliferation, apoptosis and methylation in Burkitt lymphoma cells</article-title>
<source/>J Cancer Res Clin Oncol
          <year>2018</year>
<fpage>1</fpage>
<lpage>15</lpage>
</element-citation>
</ref>
<ref id="R67">
<label>67</label>
<element-citation publication-type="journal">
<name>
<surname>He</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Gupta</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Fang</surname>
<given-names>F</given-names>
</name>
<article-title>Overexpression of micro ribonucleic acid 29, highly up-regulated in diabetic rats, leads to insulin resistance in 3T3-L1 adipocytes</article-title>
<source/>Mol Endocrinol
          <year>2007</year>
<volume>21</volume>
<issue>11</issue>
<fpage>2785</fpage>
<lpage>2794</lpage>
<pub-id pub-id-type="pmid">17652184</pub-id>
</element-citation>
</ref>
<ref id="R68">
<label>68</label>
<element-citation publication-type="journal">
<name>
<surname>Correa-Medina</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bravo-Egana</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Rosero</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ricordi</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Edlund</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Diez</surname>
<given-names>J</given-names>
</name>
<etal></etal>
<article-title>MicroRNA miR-7 is preferentially expressed in endocrine cells of the developing and adult human pancreas</article-title>
<source/>Gene Expr Patterns
          <year>2009</year>
<volume>9</volume>
<issue>4</issue>
<fpage>193</fpage>
<lpage>199</lpage>
<pub-id pub-id-type="pmid">19135553</pub-id>
</element-citation>
</ref>
<ref id="R69">
<label>69</label>
<element-citation publication-type="journal">
<name>
<surname>Kalinowski</surname>
<given-names>FC</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Ganda</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Giles</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>Epis</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Horsham</surname>
<given-names>J</given-names>
</name>
<etal></etal>
<article-title>microRNA-7: a tumor suppressor miRNA with therapeutic potential</article-title>
<source/>Int J Biochem Cell Biol
          <year>2014</year>
<volume>54</volume>
<fpage>312</fpage>
<lpage>317</lpage>
<pub-id pub-id-type="pmid">24907395</pub-id>
</element-citation>
</ref>
<ref id="R70">
<label>70</label>
<element-citation publication-type="journal">
<name>
<surname>Wang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Naji</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Stoffers</surname>
<given-names>DA</given-names>
</name>
<article-title>MicroRNA-7 regulates the mTOR pathway and proliferation in adult pancreatic β-cells</article-title>
<source/>Diabetes
          <year>2013</year>
<volume>62</volume>
<issue>3</issue>
<fpage>887</fpage>
<lpage>895</lpage>
<pub-id pub-id-type="pmid">23223022</pub-id>
</element-citation>
</ref>
<ref id="R71">
<label>71</label>
<element-citation publication-type="journal">
<name>
<surname>Wan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>CY</given-names>
</name>
<etal></etal>
<article-title>Increased serum miR-7 is a promising biomarker for type 2 diabetes mellitus and its microvascular complications</article-title>
<source/>Diabetes Res Clin Pract
          <year>2017</year>
<volume>?</volume>
</element-citation>
</ref>
<ref id="R72">
<label>72</label>
<element-citation publication-type="journal">
<name>
<surname>Mostafa</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Murad</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Mohammad</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Islam</surname>
<given-names>A</given-names>
</name>
<article-title>Intronic Mirna Mir-3666 Modulates its Host Gene FOXP2 Functions in Neurodevelopment and May Contribute to Pathogenesis of Neurological Disorders Schizophrenia and Autism</article-title>
<source/>J Appl Biotechnol Bioeng
          <year>2017</year>
<volume>2</volume>
<fpage>1</fpage>
<lpage>17</lpage>
</element-citation>
</ref>
<ref id="R73">
<label>73</label>
<element-citation publication-type="journal">
<name>
<surname>Tan</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Tong</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>Y</given-names>
</name>
<article-title>Pancreatic β-cell function is inhibited by miR-3666 in type 2 diabetes mellitus by targeting adiponectin</article-title>
<source/>Braz J Med Biol Res
          <year>2019</year>
<volume>52</volume>
<issue>6</issue>
</element-citation>
</ref>
<ref id="R74">
<label>74</label>
<element-citation publication-type="journal">
<name>
<surname>He</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Xia</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Guan</surname>
<given-names>W</given-names>
</name>
<etal></etal>
<article-title>MiR-135a promotes renal fibrosis in diabetic nephropathy by regulating TRPC1</article-title>
<source/>Diabetologia
          <year>2014</year>
<volume>57</volume>
<issue>8</issue>
<fpage>1726</fpage>
<lpage>1736</lpage>
<pub-id pub-id-type="pmid">24908566</pub-id>
</element-citation>
</ref>
<ref id="R75">
<label>75</label>
<element-citation publication-type="journal">
<name>
<surname>Honardoost</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Keramati</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Arefian</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Mohammadi Yeganeh</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Soleimani</surname>
<given-names>M</given-names>
</name>
<article-title>Network of three specific microRNAs influence type 2 diabetes through inducing insulin resistance in muscle cell lines</article-title>
<source/>J Cell Biochem
          <year>2019</year>
<volume>120</volume>
<issue>2</issue>
<fpage>1532</fpage>
<lpage>1538</lpage>
</element-citation>
</ref>
<ref id="R76">
<label>76</label>
<element-citation publication-type="journal">
<name>
<surname>Sarookhani</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Honardoost</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Foroughi</surname>
<given-names>F</given-names>
</name>
<article-title>Plasma miR-135a; a potential biomarker for diagnosis of new type 2 diabetes (T2DM)</article-title>
<source/>Bali Med J
          <year>2018</year>
</element-citation>
</ref>
<ref id="R77">
<label>77</label>
<element-citation publication-type="journal">
<name>
<surname>Sebastiani</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Grieco</surname>
<given-names>FA</given-names>
</name>
<name>
<surname>Spagnuolo</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Galleri</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Cataldo</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Dotta</surname>
<given-names>F</given-names>
</name>
<article-title>Increased expression of microRNA miR‐326 in type 1 diabetic patients with ongoing islet autoimmunity</article-title>
<source/>Diabetes Metab Res Rev
          <year>2011</year>
<volume>27</volume>
<issue>8</issue>
<fpage>862</fpage>
<lpage>866</lpage>
<pub-id pub-id-type="pmid">22069274</pub-id>
</element-citation>
</ref>
<ref id="R78">
<label>78</label>
<element-citation publication-type="journal">
<name>
<surname>Murphy</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>Ouyang</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Farrar</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Ranganath</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Asnagli</surname>
<given-names>H</given-names>
</name>
<etal></etal>
<article-title>Signaling and transcription in T helper development</article-title>
<source/>Annu Rev Immunol
          <year>2000</year>
<volume>18</volume>
<issue>1</issue>
<fpage>451</fpage>
<lpage>494</lpage>
<pub-id pub-id-type="pmid">10837066</pub-id>
</element-citation>
</ref>
<ref id="R79">
<label>79</label>
<element-citation publication-type="journal">
<name>
<surname>Du</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Ye</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>S</given-names>
</name>
<etal></etal>
<article-title>MicroRNA miR-326 regulates T H-17 differentiation and is associated with the pathogenesis of multiple sclerosis</article-title>
<source/>Nat Immunol
          <year>2009</year>
<volume>10</volume>
<issue>12</issue>
<fpage>1252</fpage>
<pub-id pub-id-type="pmid">19838199</pub-id>
</element-citation>
</ref>
<ref id="R80">
<label>80</label>
<element-citation publication-type="journal">
<name>
<surname>Jazdzewski</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Murray</surname>
<given-names>EL</given-names>
</name>
<name>
<surname>Franssila</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Jarzab</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Schoenberg</surname>
<given-names>DR</given-names>
</name>
<name>
<surname>de la Chapelle</surname>
<given-names>A</given-names>
</name>
<article-title>Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma Proc Natl Acad</article-title>
<source/>Sci
          <year>2008</year>
<volume>105</volume>
<issue>20</issue>
<fpage>7269</fpage>
<lpage>7274</lpage>
</element-citation>
</ref>
<ref id="R81">
<label>81</label>
<element-citation publication-type="journal">
<name>
<surname>Yang</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ye</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Hong</surname>
<given-names>J</given-names>
</name>
<etal></etal>
<article-title>Decreased miR‐146 expression in peripheral blood mononuclear cells is correlated with ongoing islet autoimmunity in type 1 diabetes patients</article-title>
<source/>J Diabetes
          <year>2015</year>
<volume>7</volume>
<issue>2</issue>
<fpage>158</fpage>
<lpage>165</lpage>
<pub-id pub-id-type="pmid">24796653</pub-id>
</element-citation>
</ref>
<ref id="R82">
<label>82</label>
<element-citation publication-type="journal">
<name>
<surname>Bang</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Batkai</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Dangwal</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Gupta</surname>
<given-names>SK</given-names>
</name>
<name>
<surname>Foinquinos</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Holzmann</surname>
<given-names>A</given-names>
</name>
<etal></etal>
<article-title>Cardiac fibroblast–derived microRNA passenger strand-enriched exosomes mediate cardiomyocyte hypertrophy</article-title>
<source/>J Clin Invest
          <year>2014</year>
<volume>124</volume>
<issue>5</issue>
<fpage>2136</fpage>
<pub-id pub-id-type="pmid">24743145</pub-id>
</element-citation>
</ref>
<ref id="R83">
<label>83</label>
<element-citation publication-type="journal">
<name>
<surname>Condorelli</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Latronico</surname>
<given-names>MV</given-names>
</name>
<name>
<surname>Dorn</surname>
<given-names>GW</given-names>
</name>
<article-title>microRNAs in heart disease: putative novel therapeutic targets?</article-title>
<source/>Eur Heart J
          <year>2010</year>
<volume>31</volume>
<issue>6</issue>
<fpage>649</fpage>
<lpage>658</lpage>
<pub-id pub-id-type="pmid">20118173</pub-id>
</element-citation>
</ref>
<ref id="R84">
<label>84</label>
<element-citation publication-type="journal">
<name>
<surname>McClelland</surname>
<given-names>AD</given-names>
</name>
<name>
<surname>Herman-Edelstein</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Komers</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Jha</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Winbanks</surname>
<given-names>CE</given-names>
</name>
<name>
<surname>Hagiwara</surname>
<given-names>S</given-names>
</name>
<etal></etal>
<article-title>miR-21 promotes renal fibrosis in diabetic nephropathy by targeting PTEN and SMAD7</article-title>
<source/>Clin Sci
          <year>2015</year>
<volume>129</volume>
<issue>12</issue>
<fpage>1237</fpage>
<lpage>1249</lpage>
<pub-id pub-id-type="pmid">26415649</pub-id>
</element-citation>
</ref>
<ref id="R85">
<label>85</label>
<element-citation publication-type="journal">
<name>
<surname>Chien</surname>
<given-names>HY</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>CY</given-names>
</name>
<name>
<surname>Chiu</surname>
<given-names>YH</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>YC</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>WC</given-names>
</name>
<article-title>Differential microRNA profiles predict diabetic nephropathy progression in Taiwan</article-title>
<source/>Int J Med Sci
          <year>2016</year>
<volume>13</volume>
<issue>6</issue>
<fpage>457</fpage>
<pub-id pub-id-type="pmid">27279796</pub-id>
</element-citation>
</ref>
<ref id="R86">
<label>86</label>
<element-citation publication-type="journal">
<name>
<surname>Dai</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Yin</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Nie</surname>
<given-names>X</given-names>
</name>
<etal></etal>
<article-title>MiR-21 protected against diabetic cardiomyopathy induced diastolic dysfunction by targeting gelsolin</article-title>
<source/>Cardiovasc Diabetol
          <year>2018</year>
<volume>17</volume>
<issue>1</issue>
<fpage>123</fpage>
<pub-id pub-id-type="pmid">30180843</pub-id>
</element-citation>
</ref>
<ref id="R87">
<label>87</label>
<element-citation publication-type="journal">
<name>
<surname>Van Rooij</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Sutherland</surname>
<given-names>LB</given-names>
</name>
<name>
<surname>Thatcher</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>DiMaio</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Naseem</surname>
<given-names>RH</given-names>
</name>
<name>
<surname>Marshall</surname>
<given-names>WS</given-names>
</name>
<etal></etal>
<article-title>Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis Proc Natl Acad</article-title>
<source/>Sci
          <year>2008</year>
<volume>105</volume>
<issue>35</issue>
<fpage>13027</fpage>
<lpage>13032</lpage>
</element-citation>
</ref>
<ref id="R88">
<label>88</label>
<element-citation publication-type="journal">
<name>
<surname>Beltrami</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Simpson</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Jesky</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Wonnacott</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Carrington</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Holmans</surname>
<given-names>P</given-names>
</name>
<etal></etal>
<article-title>Association of elevated urinary miR-126, miR-155, and miR-29b with diabetic kidney disease</article-title>
<source/>Am J Pathol
          <year>2018</year>
<volume>188</volume>
<issue>9</issue>
<fpage>1982</fpage>
<lpage>1992</lpage>
<pub-id pub-id-type="pmid">29981742</pub-id>
</element-citation>
</ref>
<ref id="R89">
<label>89</label>
<element-citation publication-type="journal">
<name>
<surname>Lin</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Yun</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>X</given-names>
</name>
<etal></etal>
<article-title>MicroRNA-29 regulates high-glucose-induced apoptosis in human retinal pigment epithelial cells through PTEN</article-title>
<source/>In Vitro Cell Dev Biol Anim
          <year>2016</year>
<volume>52</volume>
<issue>4</issue>
<fpage>419</fpage>
<lpage>426</lpage>
<pub-id pub-id-type="pmid">26822433</pub-id>
</element-citation>
</ref>
<ref id="R90">
<label>90</label>
<element-citation publication-type="journal">
<name>
<surname>Ghosh</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Katare</surname>
<given-names>R</given-names>
</name>
<article-title>Molecular mechanism of diabetic cardiomyopathy and modulation of microRNA function by synthetic oligonucleotides</article-title>
<source/>Cardiovasc Diabetol
          <year>2018</year>
<volume>17</volume>
<issue>1</issue>
<fpage>43</fpage>
<pub-id pub-id-type="pmid">29566757</pub-id>
</element-citation>
</ref>
<ref id="R91">
<label>91</label>
<element-citation publication-type="journal">
<name>
<surname>Zhang</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Shang</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Lv</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Su</surname>
<given-names>B</given-names>
</name>
<article-title>Circulating miR-126 is a potential biomarker to predict the onset of type 2 diabetes mellitus in susceptible individuals</article-title>
<source/>Biochem Biophys Res Commun
          <year>2015</year>
<volume>463</volume>
<issue>1</issue>
<fpage>60</fpage>
<lpage>63</lpage>
<pub-id pub-id-type="pmid">25986735</pub-id>
</element-citation>
</ref>
<ref id="R92">
<label>92</label>
<element-citation publication-type="journal">
<name>
<surname>Park</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Moon</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>IB</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>DH</given-names>
</name>
<name>
<surname>Nam</surname>
<given-names>S</given-names>
</name>
<article-title>Urinary and blood MicroRNA-126 and-770 are potential noninvasive biomarker candidates for diabetic nephropathy: a meta-analysis</article-title>
<source/>Cell Physiol Biochem
          <year>2018</year>
<volume>46</volume>
<issue>4</issue>
<fpage>1331</fpage>
<lpage>1340</lpage>
<pub-id pub-id-type="pmid">29689545</pub-id>
</element-citation>
</ref>
<ref id="R93">
<label>93</label>
<element-citation publication-type="journal">
<name>
<surname>Qin</surname>
<given-names>LL</given-names>
</name>
<name>
<surname>An</surname>
<given-names>MX</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>YL</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>HC</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>ZQ</given-names>
</name>
<article-title>MicroRNA-126: a promising novel biomarker in peripheral blood for diabetic retinopathy</article-title>
<source/>Int J Ophthalmol
          <year>2017</year>
<volume>10</volume>
<issue>4</issue>
<fpage>530</fpage>
<pub-id pub-id-type="pmid">28503423</pub-id>
</element-citation>
</ref>
<ref id="R94">
<label>94</label>
<element-citation publication-type="journal">
<name>
<surname>Babu</surname>
<given-names>SS</given-names>
</name>
<name>
<surname>Thandavarayan</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Joladarashi</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Joladarashi</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Jeyabal</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Krishnamurthy</surname>
<given-names>S</given-names>
</name>
<etal></etal>
<article-title>MicroRNA-126 overexpression rescues diabetes-induced impairment in efferocytosis of apoptotic cardiomyocytes</article-title>
<source/>Sci Rep
          <year>2016</year>
<volume>6</volume>
<fpage>36207</fpage>
<pub-id pub-id-type="pmid">27827458</pub-id>
</element-citation>
</ref>
<ref id="R95">
<label>95</label>
<element-citation publication-type="journal">
<name>
<surname>Reddy</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Villeneuve</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lanting</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Todorov</surname>
<given-names>I</given-names>
</name>
<etal></etal>
<article-title>Pro-inflammatory role of microrna-200 in vascular smooth muscle cells from diabetic mice</article-title>
<source/>Arterioscler Thromb Vasc Biol
          <year>2012</year>
<volume>32</volume>
<issue>3</issue>
<fpage>721</fpage>
<lpage>729</lpage>
<pub-id pub-id-type="pmid">22247255</pub-id>
</element-citation>
</ref>
<ref id="R96">
<label>96</label>
<element-citation publication-type="journal">
<name>
<surname>Natarajan</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Putta</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kato</surname>
<given-names>M</given-names>
</name>
<article-title>MicroRNAs and diabetic complications</article-title>
<source/>J Cardiovasc Transl Res
          <year>2012</year>
<volume>5</volume>
<issue>4</issue>
<fpage>413</fpage>
<lpage>422</lpage>
<pub-id pub-id-type="pmid">22552970</pub-id>
</element-citation>
</ref>
<ref id="R97">
<label>97</label>
<element-citation publication-type="journal">
<name>
<surname>Wang</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Koh</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Winbanks</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Coughlan</surname>
<given-names>MT</given-names>
</name>
<name>
<surname>McClelland</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Watson</surname>
<given-names>A</given-names>
</name>
<etal></etal>
<article-title>miR-200a prevents renal fibrogenesis through repression of TGF-β2 expression</article-title>
<source/>Diabetes
          <year>2011</year>
<volume>60</volume>
<issue>1</issue>
<fpage>280</fpage>
<lpage>287</lpage>
<pub-id pub-id-type="pmid">20952520</pub-id>
</element-citation>
</ref>
<ref id="R98">
<label>98</label>
<element-citation publication-type="journal">
<name>
<surname>Li</surname>
<given-names>EH</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>QZ</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>GC</given-names>
</name>
<name>
<surname>Xiang</surname>
<given-names>ZY</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X</given-names>
</name>
<article-title>Effects of miRNA-200b on the development of diabetic retinopathy by targeting VEGFA gene</article-title>
<source/>Biosci Rep
          <year>2017</year>
<volume>37</volume>
<issue>2</issue>
<fpage>BSR20160572</fpage>
<pub-id pub-id-type="pmid">28122882</pub-id>
</element-citation>
</ref>
<ref id="R99">
<label>99</label>
<element-citation publication-type="journal">
<name>
<surname>Feng</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Chu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Chu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Chakrabarti</surname>
<given-names>S</given-names>
</name>
<article-title>miR-200b mediates endothelial-to-mesenchymal transition in diabetic cardiomyopathy</article-title>
<source/>Diabetes
          <year>2016</year>
<volume>65</volume>
<issue>3</issue>
<fpage>768</fpage>
<lpage>779</lpage>
<pub-id pub-id-type="pmid">26718496</pub-id>
</element-citation>
</ref>
<ref id="R100">
<label>100</label>
<element-citation publication-type="journal">
<name>
<surname>Xiong</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Q</given-names>
</name>
<article-title>Altered retinal microRNA expression profiles in early diabetic retinopathy: an in silico analysis</article-title>
<source/>Curr Eye Res
          <year>2014</year>
<volume>39</volume>
<issue>7</issue>
<fpage>720</fpage>
<lpage>729</lpage>
<pub-id pub-id-type="pmid">24502381</pub-id>
</element-citation>
</ref>
<ref id="R101">
<label>101</label>
<element-citation publication-type="journal">
<name>
<surname>Quiat</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Olson</surname>
<given-names>EN</given-names>
</name>
<article-title>MicroRNAs in cardiovascular disease: from pathogenesis to prevention and treatment</article-title>
<source/>J Clin Invest
          <year>2013</year>
<volume>123</volume>
<issue>1</issue>
<fpage>11</fpage>
<pub-id pub-id-type="pmid">23281405</pub-id>
</element-citation>
</ref>
<ref id="R102">
<label>102</label>
<element-citation publication-type="journal">
<name>
<surname>Garcia-Morales</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Friedrich</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Jorna</surname>
<given-names>LM</given-names>
</name>
<name>
<surname>Campos-Toimil</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hammes</surname>
<given-names>HP</given-names>
</name>
<name>
<surname>Schmidt</surname>
<given-names>M</given-names>
</name>
<etal></etal>
<article-title>The microRNA-7-mediated reduction in EPAC-1 contributes to vascular endothelial permeability and eNOS uncoupling in murine experimental retinopathy</article-title>
<source/>Acta Diabetol
          <year>2017</year>
<volume>54</volume>
<issue>6</issue>
<fpage>581</fpage>
<lpage>591</lpage>
<pub-id pub-id-type="pmid">28353063</pub-id>
</element-citation>
</ref>
<ref id="R103">
<label>103</label>
<element-citation publication-type="journal">
<name>
<surname>Horsham</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Ganda</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Kalinowski</surname>
<given-names>FC</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Epis</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Leedman</surname>
<given-names>PJ</given-names>
</name>
<article-title>MicroRNA-7: A miRNA with expanding roles in development and disease</article-title>
<source/>Int J Biochem Cell Biol
          <year>2015</year>
<volume>69</volume>
<fpage>215</fpage>
<lpage>224</lpage>
<pub-id pub-id-type="pmid">26546742</pub-id>
</element-citation>
</ref>
<ref id="R104">
<label>104</label>
<element-citation publication-type="journal">
<name>
<surname>Xu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>Z</given-names>
</name>
<article-title>Functional network analysis reveals versatile microRNAs in human heart</article-title>
<source/>Cell Physiol Biochem
          <year>2015</year>
<volume>36</volume>
<issue>4</issue>
<fpage>1628</fpage>
<lpage>1643</lpage>
<pub-id pub-id-type="pmid">26160134</pub-id>
</element-citation>
</ref>
<ref id="R105">
<label>105</label>
<element-citation publication-type="journal">
<name>
<surname>Yang</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kan</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Bai</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Cha</surname>
<given-names>F</given-names>
</name>
<etal></etal>
<article-title>The effect of Baicalein on the NF-κB/P65 expression in the peripheral blood of patients with diabetic nephropathy and in vitro</article-title>
<source/>Biomedical Research
          <year>2017</year>
<volume>28</volume>
<issue>12</issue>
</element-citation>
</ref>
<ref id="R106">
<label>106</label>
<element-citation publication-type="journal">
<name>
<surname>Bijkerk</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Duijs</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Khairoun</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ter Horst</surname>
<given-names>CJH</given-names>
</name>
<name>
<surname>Van der Pol</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Mallat</surname>
<given-names>MJ</given-names>
</name>
<etal></etal>
<article-title>Circulating microRNAs associate with diabetic nephropathy and systemic microvascular damage and normalize after simultaneous pancreas–kidney transplantation</article-title>
<source/>Am J Transplant
          <year>2015</year>
<volume>15</volume>
<issue>4</issue>
<fpage>1081</fpage>
<lpage>1090</lpage>
<pub-id pub-id-type="pmid">25716422</pub-id>
</element-citation>
</ref>
<ref id="R107">
<label>107</label>
<element-citation publication-type="journal">
<name>
<surname>Wang</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Gu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>T</given-names>
</name>
<article-title>Decreased expression of miR-150, miR146a and miR424 in type 1 diabetic patients: association with ongoing islet autoimmunity</article-title>
<source/>Biochem Biophys Res Commun
          <year>2017</year>
</element-citation>
</ref>
<ref id="R108">
<label>108</label>
<element-citation publication-type="journal">
<name>
<surname>Huang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Su</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>W</given-names>
</name>
<etal></etal>
<article-title>Involvement of inflammation-related miR-155 and miR-146a in diabetic nephropathy: implications for glomerular endothelial injury</article-title>
<source/>BMC Nephrol
          <year>2014</year>
<volume>15</volume>
<issue>1</issue>
<fpage>142</fpage>
<pub-id pub-id-type="pmid">25182190</pub-id>
</element-citation>
</ref>
<ref id="R109">
<label>109</label>
<element-citation publication-type="journal">
<name>
<surname>Zhuang</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Muraleedharan</surname>
<given-names>CK</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>S</given-names>
</name>
<article-title>Intraocular delivery of miR-146 inhibits diabetes-induced retinal functional defects in diabetic rat model</article-title>
<source/>Invest Ophthalmol Vis Sci
          <year>2017</year>
<volume>58</volume>
<issue>3</issue>
<fpage>1646</fpage>
<lpage>1655</lpage>
<pub-id pub-id-type="pmid">28297724</pub-id>
</element-citation>
</ref>
<ref id="R110">
<label>110</label>
<element-citation publication-type="journal">
<name>
<surname>Copier</surname>
<given-names>CU</given-names>
</name>
<name>
<surname>León</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Fernández</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Contador</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Calligaris</surname>
<given-names>SD</given-names>
</name>
<article-title>Circulating miR-19b and miR-181b are potential biomarkers for diabetic cardiomyopathy</article-title>
<source/>Sci Rep
          <year>2017</year>
<volume>7</volume>
<issue>1</issue>
<fpage>13514</fpage>
<pub-id pub-id-type="pmid">29044172</pub-id>
</element-citation>
</ref>
<ref id="R111">
<label>111</label>
<element-citation publication-type="journal">
<name>
<surname>Surampudi</surname>
<given-names>PN</given-names>
</name>
<name>
<surname>John‐Kalarickal</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Fonseca</surname>
<given-names>VA</given-names>
</name>
<article-title>Emerging concepts in the pathophysiology of type 2 diabetes mellitus</article-title>
<source/>MT Sinai J Med
          <year>2009</year>
<volume>76</volume>
<issue>3</issue>
<fpage>216</fpage>
<lpage>226</lpage>
<pub-id pub-id-type="pmid">19421965</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>